| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2026―Feb―05 |
Individualised aerobic and resistance exercise training improves exercise tolerance in individuals with Long COVID: findings from the PERCEIVE randomised controlled trial |
E Howden, L Burnham, J Smith, K Whitmore, K Morrison, R Hoare, Y Sata, Q Huynh, T Marwick |
| 2 |
[GO] |
2026―Feb―05 |
Cardiac involvement in long COVID: echocardiographic, cardiac magnetic resonance, and endomyocardial biopsy findings in previously healthy individuals with persistent chest pain |
O G M Gomez Monterrosas, D M Martinez, G L Loyola, R J C Jimenez Cisneros, J J Jimenez |
| 3 |
[GO] |
2026―Feb―05 |
Pandemic-era shifts in acute pulmonary embolism outcomes: national inpatient sample analysis of mortality and resource utilization (2016-2021) |
M Gatuz, A Folman, L Cuenza, M Barel, R Abu-Fanne, A Roguin, O Kobo |
| 4 |
[GO] |
2026―Feb―05 |
Post-SARS-CoV-2 pandemic changes in the epidemiology and severity of MRSA-related infective endocarditis |
P Baratta, F De Sensi, F Guerrini, B Sposato, S Sparla, A Cresti, U Limbruno |
| 5 |
[GO] |
2026―Feb―05 |
Pre-existing cardiovascular disease does not augment the post-acute sequalae of SARS-CoV-2 |
J Smith, T H Marwick |
| 6 |
[GO] |
2026―Feb―05 |
A randomized, open-label study of the efficacy of trimetazidine in preventing acute myocardial injury in patients hospitalized for moderate to severe acute respiratory syndrome caused by SARS-CoV-2 |
F Gallego Lima, L H W Gowdak, R R C V Giraldez, L M Baracioli, J C Nicolau |
| 7 |
[GO] |
2026―Feb―05 |
In-hospital influenza and COVID-19 vaccine availability during acute coronary syndrome boosts vaccination rates and improves outcomes versus out-of-season patients advised post-discharge vaccination |
A Meseguer Hernandez, J M Andreu Cayuelas, F Buendia Santiago, J Merino Romero, C Azcondo San Segundo, M I Banos Maturano, E Y Mite Salazar, B De Berardinis Moreno, L Risco Eres, M B Villamarin Heredia, I Gonzalez Fernandez, B Oves Suarez, L Jaulent Huertas, M R Marmol Lozano, J A Castillo Moreno |
| 8 |
[GO] |
2026―Feb―05 |
Long term cardiac function and symptoms in patients following COVID-19 vaccination myocarditis |
M Ramadan, F Soeskov Davidovski, C Espersen, A H Al-Rubai, A Khoraizat, N D Johansen, A Hviid, T Krause, T Pareek, T Biering-Soerensen |
| 9 |
[GO] |
2026―Feb―05 |
Inpatient care and outcome of patients with acute myocardial infarction in Berlin before, during, and after the COVID-19 pandemic based on a large prospective registry |
M Maisuradze, L Bruch, A Fried, G Doerr, F Knebel, J U Roehnisch, S Spethmann, U Nimptsch, R Matteucci Gothe, M Stockburger |
| 10 |
[GO] |
2026―Feb―05 |
Impact of previous COVID-19 on functional class and echocardiographic parameters in patients with HFrEF: a retrospective study |
Y Absamatova, A Abdrakhmanov, G Smailova, G Zhusupova, A Chinybayeva, Z H Suleimen |
| 11 |
[GO] |
2026―Feb―05 |
Covid-19 and the risk of pregnancy related venous thromboembolism; a register based cohort study |
M Revelj, K Kallen, A Hagman, M Hellgren Waangdahl, Y Carlsson, E Westerlund, V Sengpiel |
| 12 |
[GO] |
2026―Feb―05 |
Pericoronary adipose tissue attenuation assessed by ultra-high-resolution CT post COVID-19 |
B Romanelli Scarpa Matuck, A Ostovaneh, M Matheson, T Thomas, J Ortman, C V Serrano Jr, A Arbab-Zadeh, J A C Lima |
| 13 |
[GO] |
2026―Feb―04 |
Comparative analysis of young acute coronary syndrome in pre and post covid pandemic |
J Cecily Mary Majella, S Sathish, R Naveen Raja, S Suriyakanth Sethupathy, R Sayee Vengatesh |
| 14 |
[GO] |
2026―Feb―04 |
COVID-19 vaccines and cardiovascular risks: a registry-based study using a self-controlled risk interval design |
A Dehghan Tarazjani, S V Belitser, D Weibel, P Van Der Harst, M Sturkenboom, F Ahmadizar |
| 15 |
[GO] |
2026―Feb―04 |
Long-term mortality predictors in post-ICU COVID-19 survivors: the role of myocardial injury and cardiovascular comorbidities |
B F O Gomes, T M B Silva, M A N A Rangel, L S Peres, L Z Peres, L C V Lima, A H G Menezes, G P Dutra, P R Carmo Junior, J L P Petriz, B B Pereira, G M M Oliveira |
| 16 |
[GO] |
2026―Feb―04 |
Impact of COVID-19 pandemic on the association between short-term exposure to PM2.5 and risk of acute myocardial infarction |
S Ikebe, M Ishii, Y Otsuka, T Nakamura, K Tsujita |
| 17 |
[GO] |
2026―Feb―04 |
Trends in digital healthcare adoption and its effectiveness for discharged patients with coronary artery disease across different phases of the COVID-19 pandemic in china |
Z Wang, L Yang, S Zhao, X Gao, Y Wu |
| 18 |
[GO] |
2026―Feb―04 |
Air temperature and thrombotic cardiovascular disease in England: a case time series analysis using whole-population electronic health records covering the COVID-19 pandemic |
I J Walter, A Sampri, T Bolton, S Boulitsakis Logothetis, Y Li, F Chalmers, J Farrel, R Denholm, S H Y Ip, L F Brizzi, A Gasparrini, A De La Cruz Libardi, A M Wood, E Raffetti |
| 19 |
[GO] |
2026―Feb―04 |
Real-world cardiovascular risk assessment, and blood pressure and LDL-cholesterol control, by different medical specialties, during and post COVID-19 pandemia (SNAPSHOT studies Romania) |
A O Ciobanu, O Vittos, B M Dolofan, N Trambitas, R Tanasescu, C Guja, D Vinereanu |
| 20 |
[GO] |
2026―Feb―04 |
Impact of covid-19 on acute heart failure admissions and in-hospital outcomes: a nationwide analysis of 2016-2021 data |
M Gatuz, S Z Cherevatsky, G Margolis, J Mohsen, D Abramov, W Abraham, M Mamas, A Roguin, O Kobo |
| 21 |
[GO] |
2026―Feb―04 |
Changing trends in myocardial infarction mortality among young adults in the United States: a 25-year analysis of disparities and the COVID-19 impact |
A Mesmar, R Abukhater, W Abdalla, E Zulfiqar, M Shahzad, S Hurjkaliani, N Abukhater, D Aljuhaymi, A T Deiab, B Elsiraj, M Usman, T Warsi, S Fadlelseed, O M Alhaj, S K M Gardezi |
| 22 |
[GO] |
2026―Feb―04 |
External validation of the ISARIC-4C mortality risk prediction score in patients hospitalized with COVID-19: Retrospective analysis of the World Heart Federation (WHF) COVID-19 Global Study |
K Singh, R Rahul, D Kondal, K Nikhare, M Jain, P Perel, K Sliwa, D Prabhakaran |
| 23 |
[GO] |
2025―Sep―08 |
Myocarditis after COVID-19, sepsis-induced cardiomyopathy, and haemodynamic assessment of heart failure: focus on the myocardium |
Filippo Crea |
| 24 |
[GO] |
2025―Aug―29 |
Correction to: Accelerated vascular ageing after COVID-19 infection: the CARTESIAN study |
|
| 25 |
[GO] |
2025―Jul―30 |
COVID-19 and vascular ageing: an accelerated yet partially reversible clock? |
Syed Bukhari, Marie D Gerhard-Herman, Behnood Bikdeli |
| 26 |
[GO] |
2025―Jun―09 |
Focus on trials: interventional cardiology, ischaemic heart disease, and long COVID |
Filippo Crea |
| 27 |
[GO] |
2025―Jun―06 |
Accelerated vascular ageing after COVID-19 infection: the CARTESIAN study |
Rosa Maria Bruno, Smriti Badhwar, Leila Abid, Mohsen Agharazii, Fabio Anastasio, Jeremy Bellien, Otto Burghuber, Luca Faconti, Jan Filipovsky, Lorenzo Ghiadoni, Cristina Giannattasio, Bernhard Hametner, Alun D Hughes, Ana Jeroncic, Ignatios Ikonomidis, Mai Tone Lonnebakken, Alessandro Maloberti, Christopher C Mayer, Maria Lorenza Muiesan, Anna Paini, Andrie Panayiotou, Chloe Park, Chakravarthi Rajkumar, Carlos Ramos Becerra, Bart Spronck, Dimitrios Terentes-Printzios, Yesim Tuncok, Thomas Weber, Pierre Boutouyrie, Herta Almhofer, Kathen Danninga, Margot Algner, Martin Wernhart, Thomas Weber, Bernhard Hametner, Christopher C Mayer, Otto Burghuber, Mohammad Azizzadeh, Marie-Kathrin Breyer, Luiz Bortolotto, Jose Fernando Vilela-Martin, Rogério Toshiro Passos Okawa, Jaqueline Lyrio Bermudes Okawa, Weimar Kunz Sebba Barroso, Emmanuel Gomes Ciolac, Vanessa Teixeira do Amaral, Bianca Fernandez, Rémi Goupil, Mohsen Agharazii, Catherine Fortier, Andrie G Panayiotou, Galatia Photiou, Jan Filipovský, Otto Mayer, Jitka Seidlerová, Petr Pazdiora, Jana Hirmerová, Lucie Šustková, Simona Bílková, Július Gelžinský, Veronika Kordíková, Štěpán Mareš, Renata Cífková, Peter Wohlfahrt, Jana Kavalírová, Rosa Maria Bruno, Pierre Boutouyrie, Hakim Khettab, Junior Justin, Diego Moriconi, Saverio Fabbri, Jean Sebastien Hulot, Antoine Fayol, Marie Courbebaisse, Beatrice Parfait, David Lebeaux, Gérard Friedlander, Jeremy Bellien, Robinson Joannides, Michele Iacob, Anne-Marie Leroi, Athanase Benetos, Ioannis Georgiopoulos, Dimitrios Terentes-Printzios, Georgia Christopoulou, Konstantinos Tsioufis, Vasiliki Gardikioti, Charalambos Vlachopoulos, Ignatios Ikonomidis, Vaia Lambadiari, Alkaternini Kountouri, Konstantinos Katogiannis, Ana Jerončić, Mario Podrug, Mirela Pavičić-Ivelja, Pjero Koren, Maria Lorenza Muiesan, Anna Paini, Massimo Salvetti, Marco Cacciatore, Giacomo Pucci, Fabio Anastasio, Elisa Scarnecchia, Cristina Giannattasio, Maloberti Alessandro, Michela Algeri, Antonella Moreo, Chiara Tognola, Andrea Grillo, Bruno Fabris, Stella Bernadi, Matteo Rovina, Giuliano Di Pierro, Lorenzo Ghiadoni, Sabina Armenia, Elisabetta Bianchini, Luca Zanoli, Pietro Castellino, Arturo Montineri, Alice Sciuto, Davide Grassi, Jolita Badariene, Ligita Ryliskyte, Agne Laucyte-Cibulskiene, Ligita Jancoriene, Kristina Ryliskiene, Agne Juceviciene, Milda Kovaite, Laura Balkeviciene, Carlos G Ramos-Becerra, Guillermos Alanis-Sánchez, Pedro Martinez-Ayala, Ernesto G Cardona-Muñóz, David Cardona-Muller, Mai Tone Lonnebakken, Caroline Annette Berge, Lucimere Bohn, José Oliveira, Emilia Alves, Simao Pedro Costa, Telmo Pereira, Armando Caseiro, Fábio Lira, Maria Rosa Bernal López, María Isabel Ruiz Moreno, Ricardo Gómez Huelgas, Almudena Lopez Sampalo, Jaime Sanz Canovas, Victor Antonio Vargas Cancela, Lidia Cobos Palacios, Juan José Mancebo Sevilla, Arzu Nazlı Zeka, Ebru Özpelit, Canet İncir, Mustafa M Barış, Yeşim Tunçok, Ali Canturk, Hasan Can Cimilli, Leila Abid, Salem Abdessalem, Selma Charfeddine, Amine Bahloul, Rania Hammami, Mahdi Walha, Alun Hughes, Chloe Park, Alexandra Jamieson, Philip J Chowienczyk, Luca Faconti, Bushra Farukh, Riaz Akhtar, Alena Shantsila, Gregory Lip, Alvaro N Gurovich, Manuel Gomez, Lee Stoner, Michelle Meyer, Erik Hanson, Gabriel Zieff, Patricia Pagan Lassalle, Lauren Bates |
| 28 |
[GO] |
2025―Mai―20 |
Myopericardial complications following COVID-19 disease and vaccination: a clinical consensus statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases |
Massimo Imazio, Cristina Basso, Antonio Brucato, Karin Klingel, Petr Kuchynka, George Lazaros, Marco Merlo, Gianfranco Sinagra, Yehuda Adler, Chiara Bucciarelli Ducci, Matteo Cameli, Silvia Castelletti, Alida Linda Caforio, Lia Crotti, Lorenzo Dagna, Andrea Frustaci, Allan Klein, Johanna Kuusisto, Angela Lopez Sainz, Renzo Marcolongo, Antonis Pantazis, Angelos G Rigopoulos, Arsen Ristic, Petar Seferovic, Mary Sheppard, Carsten Tschöpe, Thomas Lüscher |
| 29 |
[GO] |
2025―Mai―09 |
From small Dutch cohort studies to large-scale nationwide data: impact of COVID-19 on the risk of pulmonary embolism |
Florian Langer |
| 30 |
[GO] |
2025―Mrz―18 |
Incidence, risk factors, and mortality of pulmonary embolism in the Netherlands (2015-22): sex differences and shifts during the coronavirus disease 2019 pandemic |
Qingui Chen, Nienke van Rein, Luuk J J Scheres, Eva K Kempers, Chantal Visser, Marieke J H A Kruip, Suzanne C Cannegieter |
| 31 |
[GO] |
2025―Mrz―07 |
Possible perspectives for cardiovascular events following coronavirus disease 2019 vaccination |
Xue-Yan Gong, James Cheng-Chung Wei, Li-Yun Zhang |
| 32 |
[GO] |
2025―Feb―03 |
Weekly Journal Scan: Myocarditis related to COVID-19 mRNA vaccination has less severe course than those associated to SARS-Cov-2 infection or conventional aetiology |
Leonarda Galiuto, Massimo Volpe |
| 33 |
[GO] |
2025―Jan―27 |
Clarification on methodology used in the study investigating COVID-19 vaccination and cardiovascular events |
Yiyi Xu, Fredrik Nyberg |
| 34 |
[GO] |
2025―Jan―25 |
COVID-19 vaccinations in adults and evaluation of cardiovascular events: critical methodological issues |
Serafino Fazio, Elisabetta Zanolin, Paolo Bellavite |
| 35 |
[GO] |
2024―Okt―28 |
Permanent and persistent atrial fibrillation are independent risk factors of mortality after severe COVID-19 |
A Zajac, J D Kasprzak |
| 36 |
[GO] |
2024―Okt―28 |
Subclinical left ventricular dysfunction detected by speckle tracking echocardiography predicts mortality in COVID-19 patients |
E Cwiek-Rebowska, D Filipiak-Strzecka, K Cygulska, E Szymczyk, K Wdowiak-Okrojek, P Wejner-Mik, D Miskowiec, J D Kasprzak, P Lipiec |
| 37 |
[GO] |
2024―Okt―28 |
Substantial morbidity and mortality due to cardiovascular diseases in hospitalized vaccinated and un-vaccinated patients with COVID-19 from 16 countries: the WHF COVID-19 Long-term study |
K Sliwa Hahnle, L Raspail, K Singh, K Nikhare, S Akter, S H Talukder, T Kato, S Bertagnolio, J Rylance, A Banerjee, J Narula, D Pineiro, P Perel, D Prabhakaran |
| 38 |
[GO] |
2024―Okt―28 |
Vaccination status and long COVID symptoms among patients hospitalized with COVID-19: the WHF COVID-19 Long-term Study |
K Singh, D Prabhakaran, K Nikhare, L Raspail, A Banerjee, J Narula, D Pineiro, P Perel, K Sliwa Hahnle |
| 39 |
[GO] |
2024―Okt―28 |
Effects of deferment of clinic visit on cardiovascular outcomes during COVID-19 outbreak: a prospective cohort study |
A Lai, K H Hui, B Yan, G M Tan |
| 40 |
[GO] |
2024―Okt―28 |
The effect of 2 years COVID-19 pandemic on myocardial infarction and stroke admissions: nationwide registry study, sex differences and mortality |
P Sedova, R D Brown, P Ostadal, M Vrablik, J Jarkovsky, M Lichter, A Tichopad, R Mikulik, P Kala |
| 41 |
[GO] |
2024―Okt―28 |
Predictors of new-onset in-hospital atrial fibrillation in 122 089 patients admitted with COVID-19: an Australian statewide population study |
J Y A Ne, C Chow, V Chow, K Hyun, L Kritharides, D Brieger, A Ng |
| 42 |
[GO] |
2024―Okt―28 |
Predictors of B-line count in hospitalized patients with COVID-19 |
O Johannessen, C Espersen, E Platz, K G Skaarup, M C H Lassen, F S Davidovski, J Christensen, JØ Simonsen, A B Nielsen, N D Johansen, M Sengeloev, K K Iversen, M Schou, P L Myhre, T B Sorensen |
| 43 |
[GO] |
2024―Okt―28 |
A systematic assessment of myocardial involvement and cardiovascular events up to six months in patients hospitalised with COVID-19 |
N Wilmes, F W Asselbergs, J J N Daems, H T Jorstad, R G Tieleman, C Ghossein-Doha, M Linschoten |
| 44 |
[GO] |
2024―Okt―28 |
Association of COVID-19 and influenza vaccinations and cardiovascular drugs with hospitalisation and mortality in COVID-19 and Long COVID: 2-year follow-up of 17 million individuals in England |
A Dashtban, M Mizani, S Rafferty, L Pasea, C Tomlinson, Y Mu, N Islam, C Warren-Gash, S Denaxas, S Petersen, C Sudlow, K Khunti, A Banerjee |
| 45 |
[GO] |
2024―Okt―28 |
The incidence of cardiovascular conditions in patients admitted to hospital with and without COVID-19 in the South-East of Scotland |
A Bularga, F Gruber, I Lyell, D Kimenai, A Anand, K Pollock, S Sandler, N Mills |
| 46 |
[GO] |
2024―Okt―28 |
Cardiopulmonary long-term effects 6, 18 and 30 months after severe COVID-19 infection |
J H Niebauer, A Iscel, S Schedl, S Charwat-Resl, C Capelle, M Kahr, S Schamilow, M Srdits, J Faltas, M Lichtenauer, A Zoufaly, R Valenta, C Krestan, C Wenisch, D Bonderman |
| 47 |
[GO] |
2024―Okt―28 |
False-positive cardiac troponin I values in healthy athletes post COVID-19 Infection: concerning insights from a prospective cohort study |
E Kaplan, C K Kissel, L Bernasconi, P Lopez-Ayala, S Wittfooth, P Neyer, G Hure, A Sanzone, R Manka, P Noack, D Hof, O Hammarsten, A Hammerer-Lercher, C Mueller |
| 48 |
[GO] |
2024―Okt―28 |
Effect of COVID-19 pandemic on the management of hypertension and the prevalence of lifestyle disease |
T Isogaki, H Takase, N Kawakatsu, K Hayashi, F Kin, Y Dohi |
| 49 |
[GO] |
2024―Okt―28 |
The role of cardiopulmonary rehabilitation in the recovery of right ventricular function and right ventricular-pulmonary artery coupling in convalescent COVID-19 patients |
M I Gounaridi, A Vontetsianos, N Chynkiamis, P Theofilis, A Anastasiou, I Tzima, G Zakynthinos, I Gialamas, A Goliopoulou, K Kalogeras, M Vavouranakis, N Koulouris, E Oikonomou, G Siasos |
| 50 |
[GO] |
2024―Okt―28 |
How vaccination affects clinical outcomes of COVID-19 positive revascularized patients? |
O Musayev, R Dashdemirov, F Ibrahimov, G Dadashova, S H Shahbazova, Z Alimli, S Gasimzade, N Mushtagzadeh, F Aliyeva |
| 51 |
[GO] |
2024―Okt―28 |
Patients vaccinated against COVID-19 present better coronary flow, myocardial work and NTproNP levels than non-vaccinated at 4 months post COVID infection |
I Ikonomidis, A Kountouri, K Katogiannis, G Pavlidis, J Thymis, G Kostelli, E Katsanaki, K Thomas, A Antoniadou, S Tsiodras, A Frogoudaki, A R Vrettou, J Parissis, V Lambadiari |
| 52 |
[GO] |
2024―Okt―28 |
COVID-19 vaccine associated myocarditis in Norway - a nationwide validation study |
B Skinningsrud, K Vlaisavljevic, L S Oppedal, J Endresen, V Mohn, K Fladseth, T M Lysaker, J Dahl, H L Gulseth, D B Olsen, M Ribe, M E Estensen, K Broch, K H Haugaa, N E Hasselberg |
| 53 |
[GO] |
2024―Okt―28 |
Safety of COVID-19 vaccines regarding cardiovascular events: a systematic review and meta-analysis |
A Ramandi, A H Behnoush, I Khaheshi |
| 54 |
[GO] |
2024―Okt―28 |
Incidence, patient characteristics, and treatment patterns of U.S. active-duty service members diagnosed with COVID-19-associated VTE in the outpatient setting |
J Pearman, F Kelly, G Kobakhidze, Z Ganesh, A Mcquistan, E Fentanes |
| 55 |
[GO] |
2024―Okt―28 |
Types of pulmonary hypertension and prognosis in COVID-19: 18-months analysis of BNP-PL national database |
A Mamzer, M Waligora, M Kurzyna, E Mroczek, T Mularek-Kubzdela, P Pruszczyk, M Gasior, E Lewicka, D Karasek, B Kusmierczyk-Droszcz, K Mizia-Stec, K Ptaszynska, W Jachec, G Kopec, J D Kasprzak |
| 56 |
[GO] |
2024―Okt―28 |
Epidemiological, clinical, paraclinical, evolutionary, and therapeutic aspects of hypertensive patients infected by COVID-19: about 702 patients in our city |
A A Ngaide, L Fortes, I Wade, N D Gaye, J S Mingou, M Dioum, A Kane |
| 57 |
[GO] |
2024―Okt―28 |
ChineseCVD: a web-based Chinese-specifi c cardiovascular risk calculator incorporating long COVID, COVID-19vaccination, SGLT2i and PCSK9i treatment effects |
Q Lee, C Chang, G Tse, O H I Chou, T T L Lee, B K H Leung, A N Lee, A Khan, W T Wong, A K C Wai, K Chen, T Liu, J Zhou |
| 58 |
[GO] |
2024―Okt―28 |
The relationship of clinical presentation, d-dimer levels and previous SARS-CoV-2 positivity in outpatients with suspected pulmonary embolism |
I Stankovic, N Milovanovic, K Grujicic, I Vranic, N Janeski, A N Neskovic |
| 59 |
[GO] |
2024―Okt―06 |
Exercise training in long COVID: the EXER-COVID trial |
Robinson Ramírez-Vélez, Julio Oteiza, Gaizka Legarra-Gorgoñon, Sergio Oscoz-Ochandorena, Nora García-Alonso, Yesenia García-Alonso, María Correa-Rodríguez, Adrian Soto-Mota, Mikel Izquierdo |
| 60 |
[GO] |
2024―Sep―30 |
Cardiovascular events following coronavirus disease 2019 vaccination in adults: a nationwide Swedish study |
Yiyi Xu, Huiqi Li, Ailiana Santosa, Björn Wettermark, Tove Fall, Jonas Björk, Mats Börjesson, Magnus Gisslén, Fredrik Nyberg |
| 61 |
[GO] |
2024―Jul―12 |
Thrombotic risks associated with COVID-19 vaccination in atrial fibrillation or atrial flutter: no reason for alarm |
Jean M Connors |
| 62 |
[GO] |
2024―Jul―12 |
Thromboembolism after coronavirus disease 2019 vaccination in atrial fibrillation/flutter: a self-controlled case series study |
You-Jung Choi, Jaehyun Lim, Sungho Bea, Jieun Lee, Jah Yeon Choi, Seung Young Rho, Dae-In Lee, Jin Oh Na, Hyung-Kwan Kim |
| 63 |
[GO] |
2024―Jun―11 |
Pulmonary artery pseudoaneurysm due to COVID-19-associated pulmonary mucormycosis |
Zihao Li, Hongwei Zhang, Zhenhe Liu |
| 64 |
[GO] |
2024―Mrz―26 |
Third time’s a harm? Cardiac risk of SARS-CoV-2 mRNA booster vaccines in younger men |
Leslie T Cooper, Tal Hasin, Margaret Ryan |
| 65 |
[GO] |
2024―Feb―17 |
Booster vaccination with SARS-CoV-2 mRNA vaccines and myocarditis in adolescents and young adults: a Nordic cohort study |
Anders Hviid, Tuomo A Nieminen, Nicklas Pihlström, Nina Gunnes, Jesper Dahl, Øystein Karlstad, Hanne Løvdal Gulseth, Anders Sundström, Anders Husby, Jørgen Vinsløv Hansen, Rickard Ljung, Petteri Hovi |
| 66 |
[GO] |
2023―Nov―22 |
New insights on the mechanisms of myocardial injury in hypertensive patients with COVID-19 |
R Moll Bernardes, J R Ferreira, A S Sousa, E B Schaustz, M B Tortelly, A L Pimentel, A C B S Figueiredo, M M Noya-Rabelo, S Fortier, D C Albuquerque, P H Rosado De-Castro, G C Camargo, O F Souza, R R Luiz, E Medei |
| 67 |
[GO] |
2023―Nov―22 |
Examining the effect of COVID-19 on hypertrophic cardiomyopathy hospitalizations in the USA: a nationwide propensity-score matched analysis |
R Desai, A Srivastava, M Gandhi, A Perera, D Modi, M K Bellamkonda, P Sunkara, A Nanjundappa, V Akki Vivekananand, S Singh |
| 68 |
[GO] |
2023―Nov―22 |
The impact of Covid-19 on mortality and clinical characteristics in hospitalized patients with peripheral artery disease in the year 2020 |
S Piepenburg, M Maslarska, K Kaier, C Von Zur Muehlen, D Westermann, C Hehrlein |
| 69 |
[GO] |
2023―Nov―22 |
Protecting the vulnerable during a crisis - TAVR during the COVID-19 pandemic |
A Zaka, N Mridha, J Abtahi, S Anderson, D Murdoch |
| 70 |
[GO] |
2023―Nov―22 |
The COVID-19 pandemic and reduced surgical site infection following cardiac surgery: time to take up the baton |
M Jameie, S Ilkhani, M Pashang, A Bagheri, A Jalali, K H Barkhordari, M Nosrati, M Boroumand, K Hosseini, F Masoudkabir, J Bagheri |
| 71 |
[GO] |
2023―Nov―22 |
Cardiovascular risk and the COVID-19 pandemic: a retrospective observational study in a population of healthcare professionals |
G Solfanelli, A Tropea, D Giaccio, V Bucicovschi, G Gallo, G Tocci, M B Musumeci, L Marcellini, E Barbato, M Volpe, A Battistoni |
| 72 |
[GO] |
2023―Nov―22 |
Specific therapies of pulmonary hypertension and prognosis in COVID-19: 18-months analysis of BNP-PL national database |
A Mamzer, M Waligora, M Kurzyna, E Mroczek, T Mularek-Kubzdela, P Pruszczyk, I Skoczylas, E Lewicka, D Karasek, B Kusmierczyk-Droszcz, K Mizia-Stec, K Ptaszynska-Kopczynska, W Jachec, G Kopec, J D Kasprzak |
| 73 |
[GO] |
2023―Nov―22 |
Adjudicated thrombotic events in a cotemporary multicenter cohort of patients with COVID-19: findings from the CORONA-VTE Registry |
B Bikdeli, A Bejjani, C D Khairani, D Krishnathasan, A Armero, J Davies, A Assi, U Campia, Z Almarzooq, J Welker, A Sharma, B Carroll, Z Lan, S Goldhaber, G Piazza |
| 74 |
[GO] |
2023―Nov―22 |
Effect of arterial hypertension in cardiopulmonary status and right ventricle function after hospitalization for Sars-Cov-2 |
M Kariori, C Fragoulis, C Chrysochoou, D Konstantinidis, I Leontsinis, I Andrikou, P Iliakis, E Mantzouranis, K Konstantinou, T Kalos, K Grigoriou, C Aggeli, C Thomopoulos, K Tsioufis |
| 75 |
[GO] |
2023―Nov―21 |
Fighting the pandemic of heart failure: better utilization of current treatments, new drugs, and new therapeutic targets |
Filippo Crea |
| 76 |
[GO] |
2023―Nov―11 |
Speckle tracking echocardiography detects subtle right ventricular systolic dysfunction in post Covid syndrome after mild severity Covid-19 |
A Salem, H Kamel, A Shabana |
| 77 |
[GO] |
2023―Nov―11 |
Individual tailored physical training in patients with postural orthostatic tachycardia syndrome after COVID-19 - a feasibility study |
A Svensson, A Svensson-Raskh, M Stahlberg, J Bruchfeld, L Holmstroem, A Fedorowski, M Nygren-Bonnier |
| 78 |
[GO] |
2023―Nov―11 |
Comparing the effect of obesity on major adverse cardiovascular events in patients hospitalized with coronavirus disease-2019 (COVID-19): insights from the national inpatient sample (NIS) database |
E Gwira-Tamattey, R Gajjar, S Deangelo, S Shoura, N Nissan, I Asemota |
| 79 |
[GO] |
2023―Nov―11 |
Heatwaves and cardiovascular emergencies in our city, in Italy: pre-Covid-19, Covid-19 and post-Covid-19 characteristics and associated risk during heat days |
J Nawaro, L Gianquintieri, A Pagliosa, G M Sechi, E G Caiani |
| 80 |
[GO] |
2023―Nov―11 |
Lower incidence of new-onset heart disease following covid-19 compared to viral pneumonia despite more echocardiography |
T Ovrebotten, B Tholin, P L Myhre, K Stavem |
| 81 |
[GO] |
2023―Nov―11 |
Insights regarding in-hospital outcomes of COVID-19 hospitalisations and co-existing premature ventricular contractions : from national inpatient sample 2020 |
R Gajjar, T Teaima, N Battikh, I Aziz, S Shoura, Z Sad Aldeen |
| 82 |
[GO] |
2023―Nov―11 |
Incidence and risk factors of myocarditis in hospitalized patients with COVID-19 in Germany |
K Keller, I Sagoschen, S Konstantinides, T Gori, T Munzel, L Hobohm |
| 83 |
[GO] |
2023―Nov―11 |
Cardiopulmonary long-term impairment in patients 6 and 18 months post severe Covid-19 infection |
J H Niebauer, A Iscel, S Schedl, C Capelle, M Kahr, S Schamilow, R Badr-Eslam, M Lichtenauer, A Zoufaly, R Valenta, S Charwat-Resl, C Krestan, W Hitzl, C Wenisch, D Bonderman |
| 84 |
[GO] |
2023―Nov―11 |
Pro-inflammatory sensitization of platelets after a mild course of COVID-19 infection |
C Tolksdorf, E Moritz, A Hafkemeyer, K Lehmann, K Becker, T Thiele, E Schwedhelm, M Von Lucadou, M V Tzvetkov, S Engeli, G Jedlitschky, B H Rauch |
| 85 |
[GO] |
2023―Nov―11 |
Late gadolinium enhancement following Covid-19 infection does not predict outcome: a single-centre study |
K Vimalesvaran, J P Howard, S Zaman, B Ariff, A A Bharath, G Cole |
| 86 |
[GO] |
2023―Nov―11 |
Prior COVID-19 infection is associated with persistent and higher thrombus burden in acute coronary syndromes |
B To-Dang, M Zuckerman, S Cannata, R Roy, R Dalton, A Cannata, I Webb, N Melikian, J Byrne, P Maccarthy, A J A Y Shah, R Dworakowski, N Pareek |
| 87 |
[GO] |
2023―Nov―11 |
Quantitative autonomic testing after recovery from acute COVID-19 infection: comparison with findings in controls and individuals with neurogenic autonomic dysfunction |
L Mascarenhas, R Kohno, D Mcdonald, S Colburn, D Benditt |
| 88 |
[GO] |
2023―Nov―11 |
Postural orthostatic tachycardia syndrome (POTS) and other autonomic dysfunction following COVID-19 infection: incidence, characteristic and associating factors |
C Tanking, C Lakkananurak, C Srisakvarakul, S Panda, A Jitpreeda, N Leethananirawit, P Punprame, K Threechod, D Sukitpunyaroj |
| 89 |
[GO] |
2023―Nov―11 |
Reduction in acute coronary events without excess out of hospital cardiac arrest during the COVID-19 lockdown of 2020 in new South Wales, Australia |
S Fathieh, C Madronio, S Faddy, K Negishi |
| 90 |
[GO] |
2023―Nov―11 |
Risk of myocarditis requiring hospitalization following Covid-19 mRNA booster vaccinations |
R Arbel, M Yechezkel, E Shmueli, D Yamin |
| 91 |
[GO] |
2023―Nov―11 |
The COVID-19 mRNA vaccine Comirnaty induces anaphylactic shock in an anti-PEG hyperimmune large animal model |
B A Barta, T Radovits, A B Dobos, G T Kozma, T Meszaros, P Berenyi, R Facsko, B Merkely, J Szebeni |
| 92 |
[GO] |
2023―Nov―11 |
A novel model in primary prevention for coronary artery disease amid the covid-19 pandemic |
O Soran, P Gunel, D Ozveri, M Yazdic, A Kaya, N Acar, G Sofuoglu, H İ Deniz, B Zatari |
| 93 |
[GO] |
2023―Nov―11 |
Mortality after cardiovascular surgery and percutaneous coronary intervention prior to versus during the COVID-19 pandemic |
A Chu, X Wang, J M Paterson, M Hillmer, K Malikov, D S Lee |
| 94 |
[GO] |
2023―Nov―11 |
Did COVID-19 pandemic affect deaths from cardiovascular diseases in Japan? |
M Kokubo, A Shimizu, T Kamihara, A Hirashiki, H Arai |
| 95 |
[GO] |
2023―Nov―11 |
Impact of COVID-19 pandemics on the incidence and mortality in Takotsubo syndrome: a report from Swedish Coronary Angiography and Angioplasty Registry |
E Omerovic, T Gudmundsson, B Redfors, O Angeras, P Petursson, A Rawshani, O Frobert, J Alfredsson, C Ekenbeck, L Henareh, K Skoglund, C Ljungman, M Mohammad, T Jernberg, D Erlinge |
| 96 |
[GO] |
2023―Nov―11 |
Subclinical left ventricular dysfunction demonstrated by strain imaging echocardiography in moderate to severe COVID-19 patients (Delta variant, single center study) |
C W Wuttichaipradit, C T Yodwut, P Sukhum, K Hengrussamee, M Treesong, S Thiangtham, B Samut, A Tunhasiriwet |
| 97 |
[GO] |
2023―Nov―11 |
The association between obesity and mortality in otherwise metabolically healthy COVID-19 patients with cardiac arrest: insights from a National Inpatient Sample in the US, 2020 |
S Singh, M Gandhi, A Srivastava, A Perera, M K Bellamkonda, D Modi, P Sunkara, A Nanjundappa, V Akki Vivekananand, R Desai |
| 98 |
[GO] |
2023―Nov―11 |
Impact of pulmonary embolism on COVID-19 pneumonia hospitalizations: analysis of the national inpatient sample 2020 |
M Kodali, R Atluri |
| 99 |
[GO] |
2023―Nov―11 |
Multimodality imaging and immunophenotyping of COVID-19 related myocardial injury (the MIIC-MI Study) |
A Corovic, X Zhao, Y Huang, D Gopalan, J Harrison, S Chen, N Savinykh Yarkoni, A Sage, N Sithole, M R Bennett, J H F Rudd, Z Mallat, T X Zhao, M Nus, J M Tarkin |
| 100 |
[GO] |
2023―Nov―11 |
Surviving critical COVID-19 requiring mechanical ventilation is associated with a high risk of cardiovascular events post discharge |
A Liliequist, P Nordberg, M Stahlberg, R Hofmann, P Svensson |
| 101 |
[GO] |
2023―Nov―11 |
No association between COVID-19 vaccination and sudden cardiac death |
E Paratz, D Stub, A La Gerche |
| 102 |
[GO] |
2023―Nov―11 |
Increased troponin I blood level and in-hospital outcome across successive COVID-19 waves |
P R Benchimol Barbosa |
| 103 |
[GO] |
2023―Nov―11 |
The frequency of arrhythmia in patients with palpitations who had COVID-19 with 24-hour holter compared to the control group |
K Korkmaz, C Tulunay Kaya, T S Tan Kurklu |
| 104 |
[GO] |
2023―Nov―11 |
Mortality, cardiovascular disease and long covid at 3 months in individuals hospitalized with covid-19- a whf study |
K Sliwa Hahnle, K Nikhare, K Singh, L Raspail, A Banerjee, F Pinto, J Narula, D Pineiro, P Perel, D Prabhakaran |
| 105 |
[GO] |
2023―Nov―11 |
Arterial hypertension, chronic kidney and severe valvular heart disease predict worse outcome after postponing non-emergency cardiac interventions during the COVID-19-pandemic |
S Andress, D Felbel, A Mack, M Rattka, S D`Almeida, D Buckert, W Rottbauer, A Imhof, T Stephan |
| 106 |
[GO] |
2023―Nov―11 |
Myocardial infarction mortality after COVID-19: a nationwide population-based cohort study |
K D Brodersen, S P Ulrichsen, S Soerup, L Pedersen, R W Thomsen, H T Soerensen, M Schmidt |
| 107 |
[GO] |
2023―Nov―11 |
Long-term risk of pulmonary embolism and deep venous thrombosis after COVID-19: a population-based cohort study |
H Sjoland, M Lindgren, T Toska, P O Hansson, K Glise Sandblad, L Bjorck, C E Lundberg, M Adiels, A Rosengren |
| 108 |
[GO] |
2023―Nov―11 |
Impact of atrial fibrillation on mortality and non-fatal cardiovascular outcomes in 145 293 patients admitted with COVID-19: a statewide population-linkage study |
J Y A Ne, C Chow, A Yan, I Rubenis, S Virk, V Chow, K Hyun, L Kritharides, D Brieger, A Ng |
| 109 |
[GO] |
2023―Nov―11 |
Myocarditis after vaccination against COVID-19: an umbrella review of systematic review and meta-analysis |
A Bouchlarhem, S Boulouiz, N Ismaili, N El Ouafi |
| 110 |
[GO] |
2023―Nov―11 |
Adjudicated cardiovascular events in a cotemporary multicenter cohort of patients with COVID-19: findings from the CORONA-VTE Registry |
B Bikdeli, D Krishnathasan, C D Khairani, A Bejjani, A Tristani, N Porio, A Assi, U Campia, E Wei, B Tiu, J Hsia, A Vishnevsky, Z Lan, S Goldhaber, G Piazza |
| 111 |
[GO] |
2023―Nov―11 |
Clinical outcomes of cardiac devices in heart failure patients hospitalized with COVID-19: insights from the united states national inpatient database |
E Moras, K Gandhi, A Correa, K Mahmood |
| 112 |
[GO] |
2023―Nov―11 |
Risk of atrial tachycardias after covid-19: nationwide self-controlled cases series and matched cohort study |
I Katsoularis, O Fonseca Rodriguez, H Jerndal, S Kalucza, K Lindmark, A M Fors Connolly |
| 113 |
[GO] |
2023―Nov―11 |
Impact of different types of heart failure on coronavirus disease 2019 infection outcomes |
O Al-Taweel, A Gill, R Shao, T Wineinger, D Alkhatib, C Ahsan |
| 114 |
[GO] |
2023―Nov―11 |
Sequential activation of DNA viruses by the RNA virus SARS-CoV-2 in patients with long COVID syndrome |
M Gyongyosi, E Hasimbegovic, D Lukovic, K Zlabinger, A Spannbauer, E Samaha, J Bergler-Klein, C Hengstenberg, P Mucher, H Haslacher, M Breuer, R Strassl, M Riesenhuber, C Nitsche, T A Zelniker |
| 115 |
[GO] |
2023―Nov―11 |
Symptom burden, coagulopathy and heart disease, and quality of life at baseline and after 1-year follow-up following acute SARS-CoV-2 infection in a community medicine setting |
R Colleran, H Rai, S Fitzgerald, L Mcgovern, R J Byrne, A Cradock, R Lavery, J Bisset, S Mckeogh, G Cantwell, D O'ciardha, J Mcnulty, G Szeplaki, J P O'donnell, R A Byrne |
| 116 |
[GO] |
2023―Nov―11 |
Former SARS-CoV-2-Infection is related to decreased peak VO2 and exercise hyperten-sion in athletes |
K Keller, O Friedrich, J Treiber, A Quermann, B Friedmann-Bette |
| 117 |
[GO] |
2023―Nov―11 |
SARS-COV2 infection and heart failure an intricate link of mutual impact |
I Cabac-Pogorevici, V Revenco |
| 118 |
[GO] |
2023―Nov―11 |
Quality of care and long-term outcomes for patients admitted with heart failure across the pandemic. A nationwide study |
A Cannata, D Bromage, S Piper, S Hardman, J G F Cleland, T Mcdonagh |
| 119 |
[GO] |
2023―Nov―11 |
A hub-and-spoke model for cardiac ablations: utilising satellite units to tackle the challenges from the pandemic and beyond |
V G Lim, H He, T Lachlan, N Chandan, V Ashok, J Al-Sheikhli, R Siang, A Ammar, W Foster, S Panikker, T Dhanjal, S Yusuf, K Patel, F Osman |
| 120 |
[GO] |
2023―Nov―11 |
Long COVID and its cardiovascular implications: a call to action |
Ziyad Al-Aly |
| 121 |
[GO] |
2023―Jul―14 |
Addressing the pandemic of atrial fibrillation: optimization of catheter ablation and new therapeutic targets |
Filippo Crea |
| 122 |
[GO] |
2023―Jun―09 |
Addressing the pandemic of heart failure: old and new therapeutic opportunities |
Filippo Crea |
| 123 |
[GO] |
2023―Jun―02 |
COVID-19 vaccination-related myocarditis: a Korean nationwide study |
Jae Yeong Cho, Kye Hun Kim, Nuri Lee, Soo Hyeon Cho, Seung Yun Kim, Eun Kyoung Kim, Jae-Hyeong Park, Eui-Young Choi, Jin-Oh Choi, Hyukjin Park, Hyung Yoon Kim, Hyun Ju Yoon, Youngkeun Ahn, Myung Ho Jeong, Jeong Gwan Cho |
| 124 |
[GO] |
2023―Jan―25 |
Cardiovascular profile and electrocardiographic findings of hospitalized adult patients during the surge of delta and omicron variants of COVID-19 in a COVID-19 tertiary referral center |
P A O Alad, F E R Punzalan, E J B Llanes, J A M Aherrera, G G Gervacio, E B Reyes, J C Anonuevo |
| 125 |
[GO] |
2023―Jan―25 |
Cardiac rehabilitation results among patients who have undergone cardiac surgery after covid-19 infection |
N Lampus, T Ransun, A M Ambari, B Dwiputra, B Radi |
| 126 |
[GO] |
2023―Jan―25 |
An updated meta-analysis: The effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the mortality of hypertensive patients with confirmed COVID-19 infection |
M Manalili, J Dionisio |
| 127 |
[GO] |
2023―Jan―25 |
Cardiovascular Profile of patients with COVID-19 infection admitted at a tertiary hospital |
R Tugade, E Ongjoco, M Turalba, A Yabon, N Bisquera, L Gonzales, D Maderazo, E Suguitan, A Santos |
| 128 |
[GO] |
2023―Jan―25 |
Incidence of myocarditis among patients recovered from COVID-19 infection identified using cardiac magnetic resonance imaging |
R Tugade, N Palileo, A Panelo, M Correa, D Leycano, C Pawhay, J Cosare-San Pedro |
| 129 |
[GO] |
2023―Jan―25 |
Vaccination status and knowledge of CPR do not affect medical students' decision to perform BLS during the COVID-19 pandemic |
A P Bantolo, R G A Naranjilla |
| 130 |
[GO] |
2023―Jan―25 |
Modified STEMI protocol for Primary PCI during COVID-19 Pandemic:Does it prolong Door-To-Balloon performance? |
A Y Putranto, T M Haykal Putra, W A Soedarsono |
| 131 |
[GO] |
2023―Jan―25 |
Arterial thromboembolism (ATE) and mortality among COVID-19 patients in the intensive care unit (ICU): prevalence and risk factors |
H Zulkifly, F Mansor, I Abdul Halim Zaki, L C Kiok, T Ravi, M Pathmanathan |
| 132 |
[GO] |
2023―Jan―25 |
Electrocardiographic predictors of disease severity, mortality, and advanced ventilatory support among hospitalized covid-19 patients: a two year single center retrospective, cohort study |
G Vista, M Vestal |
| 133 |
[GO] |
2023―Jan―25 |
Pathophysiologic mechanism for MYOcarditis in COVID-19 VAccinations ("MYOVAx" Study) |
J Y Tan, Y W Chia, M Chan, S L Lim, C Chin, J Yap, A M Richards, Z W Teo, M R Amanullah, K H Peck, T L J Choo, H W Sim, B E Young, P Macary, K K Yeo |
| 134 |
[GO] |
2023―Jan―25 |
Perindopril Reduce SARS-COV-2 Spike-ACE2 Binding, ACE2 Overexpression and Cytokine Storm in Adipocyte Cell Infected with SARS-COV-2 |
M J Makhyan Jibril Al Farabi, H O Hanestya Oky Hermawan, P M H Primasitha Maharani Harsoyo, S G D Stavros George Drakos, I G R I Gde Rurus Suryawan, M A Meity Ardiana |
| 135 |
[GO] |
2023―Jan―25 |
Frequent need for apixaban dose adjustment for atrial fibrillation in an unselected acute medical admission population during the COVID 19 pandemic |
K K K Kyaw, I B Menown |
| 136 |
[GO] |
2023―Jan―25 |
Improving cardiovascular health behaviors through a comprehensive lifestyle intervention program during the pandemic in India |
P Chockalingam, S Rajeswari, J Shobika, R Anantharaman, M M Yusuf, G Sengottuvelu, V Chockalingam |
| 137 |
[GO] |
2022―Nov―15 |
dal-GenE was negative-not positive except for COVID-19 |
Allan D Sniderman |
| 138 |
[GO] |
2022―Okt―15 |
Autoantibodies against the cardiovascular protective BPIFB4 in hospitalized patients with COVID-19 |
E Ciaglia, F Montella, V Lopardo, R M Esposito, F Guarracino, G Spinetti, A A Maciag, M Ciccarelli, C Vitale, S G Pellegrino, B Polverino, C Izzo, C Vecchione, A A Puca |
| 139 |
[GO] |
2022―Okt―15 |
The role of cardiac troponin-I as a prognostic tool for mortality in patients hospitalized with COVID-19 |
J Quintal, A P Candjondjo, R A Coelho, A R Piteira, J S Simoes, R Pereira, D Noivo, A Reis, A Inacio, J M Farinha, A F Esteves, J S Ferreira, C Pohle, T Duarte, R Caria |
| 140 |
[GO] |
2022―Okt―15 |
The state of systolic and diastolic functions of the left ventricle and heart rate variability in patients with atrial fibrillation after infection of COVID-19 |
O S Sychov, O G Nesukay, O V Stasyshena, T V Getman, O V Sribna, O M Romanova, O Y A Ilchyshyna, S I Deyak |
| 141 |
[GO] |
2022―Okt―15 |
Impaired heart rate variability one and six months post acute COVID-19 |
S Lampsas, E Oikonomou, N Souvaliotis, A Goliopoulou, G A Papamikroulis, A Anastasiou, P Theofilis, G Zakynthinos, I Gialamas, P Pantelidis, M A Gounaridi, A Tsatsaragkou, G Siasos, D Tousoulis, M Vavuranakis |
| 142 |
[GO] |
2022―Okt―15 |
Incidence of atrial and ventricular arrhythmias in patients with CIEDs and COVID-19 |
A D Margulescu, D E Thomas, M Kakoudaki, H Cranch, J O'Dea, G Davies, A Phillips, A S Green, P Rees, J P Barry |
| 143 |
[GO] |
2022―Okt―15 |
The impact of pre-existing chronic heart failure on the intensive care treatment and outcome of old intensive care patients suffering from COVID-19 |
R R Bruno, B Wernly, G Wolff, A Artigas, B B Pinto, J C Schefold, D Kindgen-Milles, P H Baldia, M Kelm, M Beil, S Leaver, D W De Lange, B Guidet, H Flaatten, C Jung |
| 144 |
[GO] |
2022―Okt―15 |
Time-related aortic inflammatory response, as assessed with 18F-FDG PET/CT, in patients hospitalized with severely or critical COVID-19 |
E Solomou, D Terentes-Printzios, V Gardikioti, P Katsaounou, D Exarchos, D Economou, G Christopoulou, A D Kalkinis, P Kafouris, A Antonopoulos, A Kotanidou, I Datseris, K Tsioufis, C D Anagnostopoulos, C Vlachopoulos |
| 145 |
[GO] |
2022―Okt―15 |
Thrombosis-related miR-16-5p predicts the disease severity in patients hospitalised for COVID-19 |
D Keshwani, C Eyileten, Z Wicik, A Nowak, D Jakubik, S N Simoes, D C Martins-Jr, A Shahzadi, J Jarosz-Popek, M Wolska, J Siller-Matula, M Postula |
| 146 |
[GO] |
2022―Okt―15 |
Protective effects of COVID-19 vaccination on endothelial function of patients with COVID-19 |
S Lampsas, E Oikonomou, N Souvaliotis, G A Papamikroulis, T Lytra, S Sarantos, V C Mystakidi, P Pantelidis, K Kalogeras, P Theofilis, A Tsatsaragkou, G Siasos, C Tsioufis, D Tousoulis, M Vavuranakis |
| 147 |
[GO] |
2022―Okt―15 |
Investigation of the effect of the angiotensin II type 2 receptor (AT2R) agonist C21 on plasma NT-proBNP, a diagnostic biomarker, in subjects hospitalised with COVID-19 |
R Batta, G Tornling, E Rosendahl, T Bengtsson, J Raud |
| 148 |
[GO] |
2022―Okt―15 |
Galectin-3 as a possible marker for increased thrombogenicity in COVID-19 |
M Puccini, K Jakobs, J Friebel, L Reinshagen, P A Schencke, A Haghikia, U Landmesser, N Kraenkel, U Rauch |
| 149 |
[GO] |
2022―Okt―15 |
Parameters of coagulation and platelet hyperreactivity reflect an increased mortality in patients with moderate to severe COVID-19 |
K Jakobs, M Puccini, L Reinshagen, A A Alsheikh, J Friebel, U Lanmdesser, A Haghikia, N Kraenkel, U Rauch |
| 150 |
[GO] |
2022―Okt―15 |
Predictors and clinical consequences of heart damage in CMR in patients after COVID-19 |
M Chudzik, D Miskowiec, J Kapusta, M Babicki, J D Kasprzak |
| 151 |
[GO] |
2022―Okt―15 |
The use of handheld ultrasound device in cardiac examination of patients with history of COVID-19 |
D Filipiak, J D Kasprzak, P Lipiec |
| 152 |
[GO] |
2022―Okt―15 |
The role of cardiometabolic risk factors and endothelial dysfunction in serum albumin levels and capillary leak syndrome of patients with COVID-19 |
E Oikonomou, S Lampsas, V Lampadiari, E Korakas, E Bletsa, N Souvaliotis, P Theofilis, A Tsatsaragkou, G Poulakou, D Tsoukalas, P Pantelidis, S M Kyvelou, G Siasos, D Tousoulis, M Vavuranakis |
| 153 |
[GO] |
2022―Okt―15 |
Adults with congenital heart disease and COVID-19 |
N Langes, S J Maurer, C Meierhofer, N Nagdyman, F Bourier, S Holdenrieder, P Ewert, O Tutarel |
| 154 |
[GO] |
2022―Okt―15 |
Cardiac injury before and after COVID-19. A longitudinal MRI study |
J E Gonzalez, A Doltra, R J Perea, P Lapena, C Garcia-Ribas, J Reventos, G Caixal, J M Tolosana, E Guasch, I Roca-Luque, E Arbelo, M Sitges, S Prat, L Mont, T F Althoff |
| 155 |
[GO] |
2022―Okt―15 |
Dexamethasone improves cardiovascular outcomes in critically ill COVID-19, a real world scenario multicenter analysis |
P Jirak, V Van Almsick, D Dimitroulis, M Mirna, C Seelmaier, Z Shomanova, D Semo, D Dankl, M Mahringer, M Lichtenauer, U Hoppe, H Reinecke, R Pistulli, R Larbig, L Motloch |
| 156 |
[GO] |
2022―Okt―15 |
COVID-19 and acute heart failure among patients with cancer |
M Bergami, N Fabin, P Mjehovic, M Pasalic, M Scarpone, Z Vasiljevic, M Vavlukis, M L Vega Pittao, V Vukomanovic, G Mancuso, A David, G Caramori, S Nava, O Manfrini, R Bugiardini |
| 157 |
[GO] |
2022―Okt―15 |
COVID-19 and cardiovascular system: not only heart but also vascular. The effects of the infection on arterial stiffness |
A Maloberti, E Gualini, S Scarpellini, M Algeri, M Biolcati, E Grasso, C Tognola, A Moreo |
| 158 |
[GO] |
2022―Okt―15 |
D-dimer-driven versus standard prophylactic anticoagulation with fondaparinux in critically ill patients with COVID-19 and coagulopathy: an open-label, randomized controlled trial |
L H Adrian, S A Hutomo, A D S Negari |
| 159 |
[GO] |
2022―Okt―15 |
Variables associated with bleeding and thrombotic outcomes among patients admitted to the hospital with COVID-19 and elevated D-dimer: insights from the ACTION randomised clinical trial |
P G Barros E Silva, R D Lopes, R H M Furtado, A V S Macedo, B Bronhara, L P Damiani, L M Barbosa, J A Morata, E Ramacciotti, P A Martins, A L De Oliveira, V S Nunes, L E F Ritt, A T Rocha, L Tramujas |
| 160 |
[GO] |
2022―Okt―15 |
COVID-19 and the autonomic nervous system |
R A Xuereb, R G Xuereb, C Barbara, S Fava, C J Magri |
| 161 |
[GO] |
2022―Okt―15 |
COVID-19 associated Brugada pattern electrocardiogram: systematic review of case reports |
K C Chen, A Z Rathore, T Deol, K L Liu, E W Wu, J S Su, T W Wannenburg, J N C Catanzaro |
| 162 |
[GO] |
2022―Okt―15 |
Post COVID-19 cardiac magnetic resonance findings among inpatients vs outpatients |
M Klinceva, L V Veljanovska-Kiridzievska, P Z Zafirovska, E I Idoski, V A Ampova-Sokolov, T A Angjusheva, I M Milev, S I Idrizi, I N Neshkovski, Z M Mitrev |
| 163 |
[GO] |
2022―Okt―15 |
Atherosclerosis licenses for an exceeding immune response in COVID-19 disease |
J Leberzammer, W T Abplanalp, S F Glaser, B Schumacher, M Merten, M T Katschke, D John, M Vehreschild, A Zeiher, S Dimmeler, S Cremer |
| 164 |
[GO] |
2022―Okt―15 |
Expression changes of circulating ACE2 regulating-microRNA profiles in patients with COVID-19 during hospitalisation |
J Jarosz-Popek, C Eyileten, Z Wicik, A Nowak, M Wolska, A Shahzadi, D Jakubik, S N Simoes, D C Martins, J Siller-Matula, M Postula |
| 165 |
[GO] |
2022―Okt―15 |
History of heart failure and chronic kidney disease and the risk for all-cause death after COVID-19 during the three first waves in comparison to influenza outbreaks in Sweden |
V Ritsinger, J Bodegard, R Kristofi, M Thuresson, D Nathanson, T Nystrom, J W Eriksson, A Norhammar |
| 166 |
[GO] |
2022―Okt―15 |
The effect of smoking on exhaled carbon monoxide and arterial elasticity during prolonged surgical mask use in the COVID-19 era |
I Ikonomidis, K Katogiannis, K Kourea, G Kostelli, D Tsilivarakis, G Pavlidis, J Thymis, E Michalopoulou, V Prentza, V Lambadiari, D Kouretas, G Biondi-Zoccai |
| 167 |
[GO] |
2022―Okt―15 |
Cardiovascular features and risk of mortality in COVID-19 hospitalized patients in Spain during 2020. A nationwide study from the Minimum Basic Data Set |
C Risco Risco, L Ayerbe Garcia-Monzon, P Villares Fernandez, A Martin Arnau, D Andaluz Ojeda |
| 168 |
[GO] |
2022―Okt―15 |
Trends and risk factors of in-hospital mortality of patients with COVID-19 in Germany |
K Keller, I Sagoschen, S Barco, I Schmidtmann, C Espinola-Klein, S Konstantinides, T Munzel, L Hobohm |
| 169 |
[GO] |
2022―Okt―15 |
Cardiopulmonary long-term effects in patients after hospitalization due to COVID-19 infection |
J Niebauer, C Binder, A Iscel, S Klenk, C Capelle, M Kahr, S Cadjo, M Lichtenauer, A Toma, A Zoufaly, S Hoffman, S Charwat-Resl, C Krestan, C Wenisch, D Bonderman |
| 170 |
[GO] |
2022―Okt―15 |
Anxiety and depression among ambulatory and hospitalized patients with cardiovascular long-COVID-19 presentation referred to cardiology consultation after COVID-19 infection |
P Rasmus, J D Kasprzak, M Chudzik, A Lipert |
| 171 |
[GO] |
2022―Okt―15 |
COVID-19 infection and its impact on case-fatality in patients with pulmonary embolism |
L Hobohm, I Sagoschen, S Barco, I Farmakis, U Fedeli, S Koelmel, T Gori, C Espinola-Klein, T Munzel, S Konstantinides, K Keller |
| 172 |
[GO] |
2022―Okt―15 |
Coronary microvascular health in patients with prior COVID-19 infection and no known CAD |
A I Ahmed, J M Saad, Y Han, F Alahdab, M Malahfji, F Nabi, J Mahmarian, J P Cooke, W A Zoghbi, M H Al-Mallah |
| 173 |
[GO] |
2022―Okt―15 |
Impaired endothelial glycocalyx, vascular dysfunction and myocardial deformation four months after COVID-19 infection are partially improved at twelve months |
I Ikonomidis, A Kountouri, A Mitrakou, K Katogiannis, J Thymis, E Korakas, G Pavlidis, I Andreadou, C Chania, A Bamias, K Thomas, A Antoniadou, V Lambadiari, G Filippatos |
| 174 |
[GO] |
2022―Okt―15 |
Prevalence and diagnostic significance of novel 12-lead ECG patterns following COVID-19 infection in elite soccer players |
R Bhatia, A Malhotra, H MacLachlan, S Gati, A Kasiakogias, S Marwaha, N Chatrath, S Fyyaz, R Cooper, D Rakhit, A Varnava, M Esteban, G Finocchiaro, M Papadakis, S Sharma |
| 175 |
[GO] |
2022―Okt―15 |
Effects of COVID-19 infection on ECG parameters in outpatients |
H Deniz, F Deniz |
| 176 |
[GO] |
2022―Okt―15 |
Assessment of cardiac involvement in patients recovered from corona virus disease-19 (COVID-19) infection using magnetic resonance imaging |
M Florentino, S Javier, S Sawit, V Geron, J De La Rosa, P Quetua, N Rosas |
| 177 |
[GO] |
2022―Okt―15 |
Risk of acute myocardial infarction, stroke and thromboembolism following COVID-19 vaccination compared to testing positive for COVID-19 infection: a nationwide cohort study of 4.6 mio individuals |
M H Lassen, D Modin, K G Skaarup, B Claggett, S D Solomon, M Fralick, J U Staehr-Jensen, P Sivapalan, M Schou, T G Krause, A Hviid, L Koeber, C Torp-Pedersen, G Gislason, T Biering-Soerensen |
| 178 |
[GO] |
2022―Okt―15 |
Effects of lockdown on physical activity and arrhythmia burden in patients with an implantable cardioverter-defibrillator: the COVID-19 Lockdown ICD-Carelink (CLIC) study |
M A Ghossein, D Linz, D J W Van Kraaij, A M W Van Stipdonk, M De Melis, K Vernooy, J Heijman |
| 179 |
[GO] |
2022―Okt―15 |
Impact of COVID-19 on cardiac procedure activity in England and associated 30-day mortality |
M Mohamed, A Banerjee, S Clarke, M De Belder, A Goodwin, C Gale, N Curzen, M Mamas |
| 180 |
[GO] |
2022―Okt―15 |
Impact of COVID-19 on mechanical complications in ST elevation myocardial infarction |
N El Ouaddi, C Escabia, F Rueda, T Oliveras, S Montero, C Labata, M Ferrer, C Garcia-Garcia, A Bayes-Genis |
| 181 |
[GO] |
2022―Okt―15 |
The effect of COVID-19 on training in cardiology: a survey of UK cardiology trainees |
C J F Camm, A R Chapman, T R Gilpin, M Westwood, J P Greenwood, A Calver, C J Allen |
| 182 |
[GO] |
2022―Okt―15 |
ECG abnormalities and their relation to COVID-19 outcomes - a WHF study |
M Martins Pinto Filho, G M M Paixao, C P M Soares, P R Gomes, L Raspail, V Rossi, K Singh, P Perel, D Prabhakaran, K Sliwa-Hahnle, A L P Ribeiro |
| 183 |
[GO] |
2022―Okt―15 |
Clinical outcome of patients with severe malignant pericardial effusion due to neoplastic disease undergoing percutaneous balloon pericardiotomy during COVID-19 pandemic |
E Alfonso Rodriguez, G Lopez Cabrera, L L Llerena Rojas, L Rodriguez Nande, L Lopez Ferrero, J Echarte Martinez |
| 184 |
[GO] |
2022―Okt―15 |
Aggression, mini-aggression, and abuse against health care workers during the COVID-19 pandemic |
S Garcia-Zamora, L Pulido, M Antoniolli, D Garcia, G Perez, M Priotti, E Zaidel, R Lopez-Santi, G Vazquez, D X Chango-Azanza, R Nunez-Mendez, L T Cabral, A Sosa-Liprandi, A F Miranda-Arboleda, A Baranchuk |
| 185 |
[GO] |
2022―Okt―15 |
Investigating monotherapy and combination therapy trends in newly diagnosed patients with pulmonary arterial hypertension among EU3 & UK physicians over the COVID-19 pandemic |
D Chandler, N Syarmimi, L Gill, N Allie |
| 186 |
[GO] |
2022―Okt―15 |
COVID-19 pandemic affects STEMI numbers and in-hospital mortality: results of a nationwide analysis in Germany |
V Oettinger, A Heidenreich, M Zehender, C Bode, P Stachon, K Kaier, C Von Zur Muehlen |
| 187 |
[GO] |
2022―Okt―15 |
A blueprint for the continuation of comprehensive cardiac rehabilitation during the COVID-19 pandemic. An Australian single hospital experience |
R Zecchin, C Dickson, J Hungerford, J Leow, G Lindsay, R Mander, I Saliba, A R Denniss |
| 188 |
[GO] |
2022―Okt―15 |
COVID-19 pandemic and cardiovascular mortality and morbidity in the Czech Republic |
J Bruthans, J Rychtarikova, J Jarkovsky |
| 189 |
[GO] |
2022―Okt―15 |
Women in cardiology leadership of randomized clinical trials and participation of women in late-breaking clinical trials: has the COVID-19 pandemic changed a thing or not exactly? |
B Parapid, H Hachemi, F A Cader, M Alasnag, M Asanin, J Siller-Matula, M Trofenciuc, R M Bond, R Waksman, R Kataria, J Katsa, A Mischie, J Milin Lazovic, V Kanjuh, N Kass Wenger |
| 190 |
[GO] |
2022―Okt―15 |
Effects of the COVID-19 pandemic on offering and acceptance in a cardiac rehabilitation programme: introduction of a remote CR programme |
M Sestayo Fernandez, M Alonso Vazquez, A Gonzalez Maestro, V Gonzalez Salvado, J R Gonzalez Juanatey, C Pena Gil |
| 191 |
[GO] |
2022―Okt―15 |
Impact of COVID-19 pandemic on the occurrence and outcome of cardiogenic shock complicating acute myocardial infarction |
Z Motovska, O Hlinomaz, M Hromadka, P Kala, A Klechova, J Precek, J Kettner, J Mrozek, J Cervinka, J Matejka, A Zohor, J Bis, J Jarkosvky |
| 192 |
[GO] |
2022―Okt―15 |
Takostubo syndrome during the COVID-19 pandemic: a single center experience |
L Rallidis, D Iordanidis, N Kosmas, E Kiouri, K Papathanasiou, S Vlachos, G Filippatos |
| 193 |
[GO] |
2022―Okt―15 |
Mortality related to pulmonary embolism in the United States before and during the COVID-19 pandemic: an analysis of the CDC Multiple Cause of Death database |
I Farmakis, L Valerio, A C Mavromanoli, B Bikdeli, J M Connors, G Giannakoulas, S Z Goldhaber, L Hobohm, B J Hunt, K Keller, F A Klok, A C Spyropoulos, N Kucher, S Konstantinides, S Barco |
| 194 |
[GO] |
2022―Okt―15 |
Impact of COVID-19 pandemics upon nationwide pulmonary hypertension cohort: 18-months analysis of BNP-PL national database |
A Mamzer, J D Kasprzak, M Waligora, M Kurzyna, E Mroczek, T Mularek-Kubzdela, P Pruszczyk, E Lewicka, D Karasek, B Kusmierczyk-Droszcz, K Mizia-Stec, K Ptaszynska-Kopczynska, I Skoczylas, P Blaszczak, G Kopec |
| 195 |
[GO] |
2022―Okt―15 |
Evaluation of cardiovascular autonomic dysfunction in symptomatic post COVID-19 patients |
A M Noureldin, M Bassem, Z Abdelsalam |
| 196 |
[GO] |
2022―Okt―15 |
Admission serum magnesium levels associated with short- and long-term clinical outcomes in COVID-19 patients |
A Segev, A Sagir, S Matezky, A Segev, S Atar, M Shechter |
| 197 |
[GO] |
2022―Okt―15 |
Major adverse cardiac events in critically ill COVID-19 patients |
V Lopes, J P Baptista, N Moreira, L Goncalves |
| 198 |
[GO] |
2022―Okt―15 |
Impact of dexamethasone on cardiac injury in critically ill COVID-19 patients |
V Van Almsick, P Jirak, D Dimitroulis, M Mirna, C Seelmaier, Z Shomanova, D Semo, D Dankl, M Mahringer, M Lichtenauer, U Hoppe, H Reinecke, R Larbig, L Motloch, R Pistulli |
| 199 |
[GO] |
2022―Okt―15 |
Atrial fibrillation in COVID-19 patients admitted to an intensive care unit: prevalence and prognosis |
V Lopes, J P Baptista, N Moreira, L Goncalves |
| 200 |
[GO] |
2022―Okt―15 |
Specific characteristics of STEMI in COVID-19 patients and their practical implications: a systematic review |
M Gitto, L Novelli, O Cozzi, B Reimers, G Condorelli, G G Stefanini |
| 201 |
[GO] |
2022―Okt―15 |
Outcomes of COVID-19 patients with STEMI undergoing primary PCI |
P Kleczynski, L Niewiara, A Kulbat, M Kaczynski, T Pawlowski, S Socha`, T Rakowski, R Gil, S Bartus, J Legutko |
| 202 |
[GO] |
2022―Okt―15 |
Optimal thromboprophylaxis and anticoagulant strategies in patients with COVID-19 pneumonia. The PROTHROMCOVID Trial |
N Munoz-Rivas, J Aibar Gallizo, C Gabara-Xanco, A Trueba-Vicente, A Urbelz-Perez, V Gomez-Del Olmo, P Demelo-Rodriguez, A Rivera-Gallego, P A U Bosch-Nicolau, J A Nieto Rodriguez, M Rios-Prego, O Madridano-Cobo, M Mendez, J A Hernandez-Rivas, J Torres-Macho |
| 203 |
[GO] |
2022―Okt―15 |
The effectiveness of a telemedical program for COVID-19 positive high-risk patients in domestic isolation |
L Brunelli, L Poelzl, J Hirsch, C Engler, F Naegele, T Egelseer-Bruendl, T Scheffauer, C Rassel, C Schmit, F Nawabi, A Luckner-Hornischer, A Bauer, G Poelzl |
| 204 |
[GO] |
2022―Okt―15 |
Comparison of thrombus burden in patients with COVID-19 presenting with ST-segment elevation myocardial infarction across the three waves of outbreak in the United Kingdom |
Z Teoh, K Rathod, A Tyrlis, F Choudry, K Comer, O Guttmann, A Jain, A Wragg, A Archbold, A Baumbach, A Mathur, D Jones |
| 205 |
[GO] |
2022―Okt―15 |
Long-term effects of coronavirus disease 2019 on the cardiovascular system: the CV COVID-19 registry |
V Arevalos Rivas, L Ortega-Paz, D Fernandez-Rodriguez, V A Jimenez-Diaz, J Baneras Rius, G Campo, J F Diaz, C Scardino, M Rodriguez-Santamarta, N Gonzalo, A Perginotti, F Alfonso, I Amat-Santos, M Sabate, S Brugaletta |
| 206 |
[GO] |
2022―Okt―15 |
Long COVID-19 syndrome: association of cardiopulmonary impairment with a persistent platelet activation |
M Camera, M Brambilla, P Canzano, A Becchetti, M Conti, P G Agostoni, M Pengo, E Tortorici, M E Mancini, D Andreini, A Bonomi, G F Parati |
| 207 |
[GO] |
2022―Okt―15 |
Blood pressure alterations in recently COVID-19 vaccinated patients |
E Sanidas, D Papadopoulos, T Anastasiou, M Velliou, E Michalaki, A Fotsali, S Golemati, M Mantzourani, J Barbetseas |
| 208 |
[GO] |
2022―Okt―15 |
COVID-19 vaccination in adults with congenital heart disease: results of 1-year prospective study |
A S Roma, F Fusco, G Papaccioli, M Abbate, G Scognamiglio, A Merola, M Palma, A Correra, N Borrelli, R Barracano, N Grimaldi, D Colonna, E Romeo, B Sarubbi |
| 209 |
[GO] |
2022―Okt―15 |
Risk of worsening heart failure and all-cause mortality following mRNA COVID-19 vaccination in patients with heart failure: a Danish nationwide real-world safety study |
C Sindet-Pedersen, F Michalik, J Emanuel Strange, D Moelager Christensen, T Alexander Gerds, C Andersson, F Folke, T Biering-Soerensen, E Fosboel, C Torp-Pedersen, G Hilmar Gislason, L Koeber, M Schou |
| 210 |
[GO] |
2022―Okt―15 |
COVID-19 vaccination in the pediatric age and risk for myocarditis |
A Aimo, M Cantinotti, G Panichella, A Clerico |
| 211 |
[GO] |
2022―Okt―15 |
Acute effects of COVID-19 vaccination on inflammatory, macrovasular and microvascular biomarkers |
D Terentes-Printzios, V Gardikioti, E Solomou, E Emmanouil, I Gourgouli, P Xydis, G Christopoulou, C Georgakopoulos, I Dima, A Miliou, G Lazaros, M Pirounaki, K Tsioufis, C Vlachopoulos |
| 212 |
[GO] |
2022―Okt―15 |
COVID-19 vaccine-induced myocarditis vs. immune checkpoint inhibitor-induced myocarditis - same but different? |
L Zornitzki, O Havakuk, Z Rozenbaum, D Viskin, A Arbel, S Banai, Y Topilsky, M Laufer-Perl |
| 213 |
[GO] |
2022―Okt―15 |
Cardiac MRI findings in COVID-19 vaccine-related myocarditis: pooled analysis of 435 patients |
P Samimisedeh, E Jafari Afshar, N Shafiabadi, H Rastad |
| 214 |
[GO] |
2022―Okt―15 |
Constructing custom-made radiotranscriptomic signatures from CT angiograms: an application in COVID-19 vascular inflammation |
C P Kotanidis, C Xie, M Siddique, K Burnham, H Lockstone, R Kotronias, H West, J Rodrigues, D Adlam, S Neubauer, K Channon, J Deanfield, L P Ho, C Antoniades |
| 215 |
[GO] |
2022―Okt―15 |
Factors of persistent limited exercise tolerance in patients after COVID-19 with normal left ventricular ejection fraction |
K Gryglewska, A Sakowicz, M Banach, M Maciejewski, A Bielecka-Dabrowa |
| 216 |
[GO] |
2022―Okt―15 |
Prognostic value of brain natriuretic peptide in COVID-19 with or without acute heart failure |
M Bergami, O Manfrini, E Cenko, M Dorobantu, I Demiri, O Fronea, S Kedev, P Mjehovic, M Pasalic, L Poposka, M Stefanovic, M Vavlukis, D Milicic, M Zdravkovic, R Bugiardini |
| 217 |
[GO] |
2022―Okt―15 |
Combined anticoagulant and antiplatelet therapy is associated with an improved outcome in hospitalised patients with COVID-19: a propensity matched cohort study |
K Matli, N Chamoun, A Fares, V Zibara, S Al-Osta, R Nasrallah, P Salameh, J Mokhbat, G Ghanem |
| 218 |
[GO] |
2022―Okt―15 |
Aspirin therapy on prophylactic anticoagulation for hospitalized patients with COVID-19: a propensity score-matched cohort analysis of the HOPE-COVID-19 registry |
F Santoro, I Nunez Gil, E Vitale, J Perez-Villacastin, A Fernandez-Ortiz, N D Brunetti |
| 219 |
[GO] |
2022―Okt―15 |
No cardiac sequelae after COVID-19: results of the one year follow-up with echocardiography and biomarkers |
M Radvan, M Kamenik, L Koc, G Matejova, E Bartecku, J Horinkova, R Stepanova, P Kala |
| 220 |
[GO] |
2022―Okt―15 |
Impact of coronavirus disease 2019 on adult patients with congenital heart disease |
I Cardoso, T Branco, A Constante, J Viegas, A Grazina, B Teixeira, S Jacinto, A Castelo, T Rito, D Martins, R Ferreira, L Sousa |
| 221 |
[GO] |
2022―Okt―15 |
Effect of real-time remote-based cardiac rehabilitation on subjective satisfaction and objective performance during the coronavirus disease 2019 pandemic |
Y Fukuta, S Arizono, S Tanaka, T Kawaguchi, T Fuseya, N Tsugita, J Magata, Y Tawara, T Segawa |
| 222 |
[GO] |
2022―Okt―15 |
Prediction of clinical outcomes in patients with coronavirus disease 2019 using high-sensitive troponin I and N-terminal pro-B-type natriuretic peptide |
M Sano, T Toyota, T Morimoto, T Okada, Y Sasaki, T Taniguchi, K Kim, A Kobori, N Ehara, M Kinoshita, A Doi, K Tomii, Y Kihara, Y Furukawa |
| 223 |
[GO] |
2022―Okt―15 |
High sensitivity troponin I and newly/recently diagnosed coronavirus-19 disease patients presenting to the emergency department: values above and below the 99th percentile predict 28 day mortality |
R M Nowak, G Jacobsen, B Cook, S Linoj, M Moyer, D Lanfear |
| 224 |
[GO] |
2022―Okt―15 |
Cardiac dysrhythmias among coronavirus-19 recovered symptomatic patients |
D Shamia, G Tsaban, L Baham, Y Raviv, M Haim |
| 225 |
[GO] |
2022―Okt―15 |
The association of angiotensin-converting enzyme inhibitors and angiotensin 2 receptor blockers with renal protection in patients with SARS-CoV-2 |
A D Douen, S T Tan, M S Sukoo-Pertab, C B Bowser, O B Busari, W S Siu, P R Panetti, S K Kedarisetti, W R Romney, R P Ramdass, W L Lee, G J Juang, A T Toreli, A S Soni |
| 226 |
[GO] |
2022―Okt―15 |
Atrial fibrillation incidence in SARS-CoV-2 infected patients: predictors and relationship with in-hospital mortality |
A Maloberti, C Giannattasio, P Rebora, G Occhino, N Ughi, S Fabbri, I Cartella, M Algeri, S Scarpellini, C Rossetti, O M Epis, G Molon, P Bonfanti, M G Valsecchi, S Genovesi |
| 227 |
[GO] |
2022―Okt―15 |
Mid- and long-term atrio-ventricular mechanics in children after recovery from asymptomatic or mildly symptomatic SARS-CoV-2 infection |
J Sabatino, D Sirico, C Di Chiara, P Pogacnik, A Di Candia, F Bonfante, D Dona, P Costenaro, J Fumanelli, E Reffo, B Castaldi, R Biffanti, A Cerutti, C Giaquinto, G Di Salvo |
| 228 |
[GO] |
2022―Okt―15 |
Cardiac impairment in Long Covid 1-year post SARS-CoV-2 infection |
A Roca-Fernandez, M Wamil, A Telford, V Carapella, A Borlotti, D Monteiro, H Thomaides-Brears, A Dennis, R Banerjee, M D Robson, G Y H Lip, S Bull, M Heightman, N Ntusi, A Banerjee |
| 229 |
[GO] |
2022―Okt―15 |
Prevalence of abnormalities on cardiac MRI in unselected patients after recovery from acute SARS-CoV-2 infection and correlation with markers of immunity and coagulation: the SETANTA study |
R Colleran, R J Byrne, A Cradock, D O Ciardha, S McKeogh, H Wilson, A Mansur, J Bisset, G Cantwell, M Hannan, M Fitzgibbon, J O Donnell, H Rai, R A Byrne |
| 230 |
[GO] |
2022―Okt―15 |
No deterioration in function or volumetric parameters in elite athletes after SARS-CoV-2 infections compared to non-infected athletes: results from the ELITE cohort |
J Van Hattum, S M Verwijs, J J N Daems, S M Boekholdt, M Groenink, R N Planken, R D Van Luijk-Snoeks, A Van Der Randen, M H Moen, C A C M Wijne, A J Nederveen, Y M Pinto, A A M Wilde, H T Jorstad |
| 231 |
[GO] |
2022―Okt―15 |
SARS-CoV-2 is associated withabnormal biomarkers of oxidative stress,and endothelial function linked with cardiovascular dysfunction four months after the infection |
I Ikonomidis, A Kountouri, A Mitrakou, J Thymis, K Katogiannis, E Korakas, C Varlamos, A Bamias, K Thomas, I Andreadou, M Tsoumani, D Kavatha, A Antoniadou, M A Dimopoulos, V Lambadiari |
| 232 |
[GO] |
2022―Okt―15 |
Association between cardiovascular comorbidities and hospital admission in SARS-CoV-2 patients |
A D Douen, S T Tan, W S Siu, R P Panetti, M S Sukoo-Pertab, C B Bowser, O B Busari, W R Romney, P R Ramdass, G J Juang, A T Toreli |
| 233 |
[GO] |
2022―Okt―15 |
Apabetalone, a BET inhibitor, attenuates inflammation induced by viral RNA mimetic and reduces SARS-CoV-2 spike protein binding regardless of variants |
L Fu, D Gilham, S Stotz, C Sarsons, B Rakai, L Tsujikawa, S Wasiak, J Johansson, M Sweeney, N Wong, E Kulikowski |
| 234 |
[GO] |
2022―Okt―15 |
SARS-CoV-2 vaccination and myocarditis in a highly vaccinated New Zealand population |
C Greer, M Daly, R Troughton, P D Adamson |
| 235 |
[GO] |
2022―Okt―15 |
Classic and genetic cardiovascular risk burden and case-fatality from SARS-CoV-2 virus infection. The CARGENCORS study |
A Camps-Vilaro, I R Degano, R Brugada, M Pinsach, R Elosua, R Ramos, R Marti, I Subirana, X Nogues, J R Masclans, J Marin, R Guerri, H Tizon, B Vaquerizo, J Marrugat |
| 236 |
[GO] |
2022―Okt―15 |
Non-contrast cardiac magnetic resonance imaging after SARS-CoV2 infection or vaccination in asymptomatic adolescents: insights from the EnIGMA study |
R Parraga, C Real, I Garcia-Lunar, G Pizarro, J Sanchez-Gonzalez, R Diaz-Munoz, E Gonzalez-Calvo, E Gutierrez-Ortiz, J Martinez-Gomez, M De Miguel, A De Cos-Gandoy, P Bodega, G Santos-Beneit, V Fuster, R Fernandez-Jimenez |
| 237 |
[GO] |
2022―Okt―15 |
Long COVID syndrome: a case-control study |
R A Xuereb, A Gatt, K Vella, R G Xuereb, C J Barbara, S Fava, C J Magri |
| 238 |
[GO] |
2022―Okt―14 |
Ventricular-arterial coupling impairment in patients recovered from COVID-19 |
S Lampsas, E Oikonomou, N Souvaliotis, A Anastasiou, O Katsarou, A Marathonitis, A Lysandrou, I Tzima, S Sarantos, K Kalogeras, A Tsatsaragkou, V C Mystakidi, G Siasos, D Tousoulis, M Vavuranakis |
| 239 |
[GO] |
2022―Okt―14 |
The prognostic value of speckle tracking echocardiography in patients hospitalized with COVID-19 |
E Cwiek-Rebowska, J D Kasprzak, D Filipiak-Strzecka, E Szymczyk, K Wdowiak-Okrojek, P Wejner-Mik, K Cygulska, K Kupczynska, B Michalski, D Miskowiec, P Lipiec |
| 240 |
[GO] |
2022―Okt―14 |
Subclinical myocardial dysfunction in patients with persistent dyspnea one year after COVID-19 |
M L Luchian, A Motoc, B Roosens, J Magne, H Chameleva, J Geers, B Von Kemp, L Houard, K Van Den Bussche, S Boeckstaens, T De Potter, S Lochy, C Weytjens, S Droogmans, B Cosyns |
| 241 |
[GO] |
2022―Okt―14 |
Evaluation of myocardial work in patients recovered from the severe form of COVID-19 |
T L F Sousa, M J N N Alves, M D T Melo, A L P Albuquerque, J G Martins, L F B Botelho |
| 242 |
[GO] |
2022―Okt―14 |
Comparison of COVID-19 clinical course between LVAD recipients implanted before and during COVID-19 pandemic |
S Wisniowska-Smialek, P Rubis, I Gorkiewicz-Kot, G Wasilewski, M Kaleta, D Sobczyk, E Dziewiecka, B Kapelak, K Wierzbicki |
| 243 |
[GO] |
2022―Okt―14 |
Long-term mayor adverse cardiovascular events after COVID-19 infection: a clinical score from a cohort of 2575 patients enrolled in the multicenter international HOPE 2 registry |
F Santoro, N Di Nunno, A Centola, R Cetera, V Le Rose, J Perez-Villacastin, A Fernandez-Ortiz, I Nunez Gil, N D Brunetti |
| 244 |
[GO] |
2022―Okt―14 |
Abnormal echocardiographic findings after COVID-19 infection: a multicenter registry |
S Garcia-Zamora, J M Picco, A J Lepori, M I Galello, A K Saad, M Ayon, N Monga-Aguilar, I Shehadeh, C F Manganiello, C Izaguirre, L N Fallabrino, S Ghibaudo, M Priotti, P M Merlo, N Gastaldello |
| 245 |
[GO] |
2022―Okt―14 |
The impact of COVID-19 on right ventricular function in chronic kidney disease patients |
L Tapoi, C Ureche, A Diaconu, V Vasiliu, L Siriteanu, T Andrian, A Stefan, C Baluta, M Apetrii, G Dodi, I Nistor, M Onofriescu, R Sascau, C Statescu, A Covic |
| 246 |
[GO] |
2022―Okt―14 |
COVID-19 pandemic impact on heart failure epidemiology and outcomes in Poland. National database study |
M Zaleska-Kociecka, M Celinska-Spodar, K Podwojcic, M Maluchnik, D Walkiewicz, T Hryniewiecki, P Leszek |
| 247 |
[GO] |
2022―Okt―14 |
Impact of in-hospital medical management for COVID-19 pandemic on door-to-balloon time in patients with ST-elevation myocardial infarction |
A Takasaki, T Kurita, M Yanagisawa, A Ino, D Hiramatsu, A Ikmi, H Ito, T Kato, S Fukuoka, T Sugimoto, T Nakata, J Masuda, M Tanabe, H Kakimoto, K Dohi |
| 248 |
[GO] |
2022―Okt―14 |
1-year mortality after myocardial injury in COVID-19 patients |
B F O Gomes, T M B Silva, G P Dutra, L S Peres, N D Camisao, I R R Menezes, H C Goudar, A Butter, J L F Petriz, P R Carmo Junior, B B Pereira, G M M Oliveira |
| 249 |
[GO] |
2022―Okt―14 |
Use of artificial intelligence for point-of-care echocardiographic assessment of left ventricular ejection fraction among COVID-19 patients |
Z Dadon, N Levi, A Orlev, D Belman, A Butnaru, M Glikson, S Gottlieb, E A Alpert |
| 250 |
[GO] |
2022―Okt―14 |
Monitoring of the lung fluid status in hospitalized COVID-19 patients for predicts outcome. Results of the IMPEDANCE-Corona Trial |
M Kleiner Shochat, J Mohsen, M Abu Rumi, E Hellou, M Abolil, C Singer, M Kazatsker, O Kobo, A Roguin, S Meisel |
| 251 |
[GO] |
2022―Okt―14 |
COVID-19 vaccination decrease the risk of Intensive Care Unit hospitalisation in heart failure patients even in the time of Omicron variant: population based study |
J Parenica, J Jarkovsky, K Benesova, J Hlasensky, M Miklikova, P Kala, T Ondrus, P Lokaj, L Dusek |
| 252 |
[GO] |
2022―Okt―14 |
The impact of long COVID on myocardial work performance |
M L Luchian, A Motoc, B Roosens, J Magne, K Van Den Bussche, H Chameleva, T De Potter, L Houard, S Droogmans, B Cosyns |
| 253 |
[GO] |
2022―Aug―19 |
European Heart Journal paper on COVID-19 scoops top award for London-based researcher |
Judith Ozkan |
| 254 |
[GO] |
2022―Jun―17 |
Placing the risk of myopericarditis following COVID-19 vaccination into perspective |
Giovanna Liuzzo, Carlo Patrono |
| 255 |
[GO] |
2022―Apr―13 |
Increased risk of incident diabetes in patients with long COVID |
Francesco Paneni, Carlo Patrono |
| 256 |
[GO] |
2022―Mrz―14 |
European Society of Cardiology guidance for the management of cardiovascular disease during the pandemic and a focus on long COVID |
Filippo Crea |
| 257 |
[GO] |
2022―Feb―18 |
Not only lungs: COVID-19 hits platelets as well |
Dario Bongiovanni, Melissa Klug, Marco Valgimigli, Isabell Bernlochner |
| 258 |
[GO] |
2022―Feb―08 |
The association between neutrophil to lymphocyte ratio and echocardiographic parameters in hospitalised adults with COVID-19 - a retrospective analysis |
R Agarwal, G Priyonugroho, S Hertine, S H Wicaksono, P Almazini, D Zamroni, H S Muliawan |
| 259 |
[GO] |
2022―Feb―08 |
Demographic analysis and clinical outcomes of COVID-19 and myocardial infarction from a tertiary care centre in south India |
R Kongara, RAMESH Sankaran, T R Muralidharan, P Manokar, S Sadhanandham, S Nagendra Boopathy, B Vinod Kumar, J V Balasubramaniyan, K Preetham |
| 260 |
[GO] |
2022―Feb―08 |
Palliative care for patients with cardiovascular disease and COVID-19 in a major referral hospital |
T Correa, A M S Simao, J V B Sobreira, F Yarshell, F B Anbar, R T De Carvalho |
| 261 |
[GO] |
2022―Feb―08 |
The association between transthoracic echocardiographic parameters and severity of COVID-19 in hospitalised adults - a retrospective analysis |
R Agarwal, G Priyonugroho, S Hertine, S H Wicaksono, P Almazini, D Zamroni, H S Muliawan |
| 262 |
[GO] |
2022―Feb―08 |
Symptomatology, prognosis and clinical findings of myocarditis as an adverse event of COVID-19 mRNA vaccine: a systematic review |
VIKASH Jaiswal, AKASH Jaiswal, NITYA Batra, D Mukherjee, R Ruchika, ANGELA Ishak, U Maskey, GAZALA Hitawala, DAVID Song, YASAR Sattar |
| 263 |
[GO] |
2022―Feb―08 |
Impact of Covid-19 on cardiovascular clinics: are we ready for tele-medicine? |
M Mujtaba, FAISAL Khanzada, DANISH Qayyum, TAHIR Saghir, SHARF Buraro |
| 264 |
[GO] |
2022―Feb―08 |
Effectiveness of a home-based cardiovascular disease prevention program during the COVID-19 pandemic |
P Chockalingam, V Natarajan, T Sekar, A Rajaram, M M Yusuf, S Gunasekaran, P G Nayar, V Chockalingam |
| 265 |
[GO] |
2022―Feb―08 |
Virtual medical research mentoring and collaboration: breaking the bounds of nationality during the COVID-19 pandemic |
J S K Chan, D H H Lau, E King, Y K L Shum, L Roever, T Liu, K Ng, E C Dee, A Ciobanu, G Bazoukis, E Mahmoudi, D I Satti, K Jeevaratnam, A Baranchuk, G Tse |
| 266 |
[GO] |
2022―Feb―08 |
Impact of the anti-hypertensive diets virtual education towards knowledge, attitude, practice, and reduction of blood pressure during covid-19 pandemic |
A Andrianto, M Ardiana, A Yutha, B P D Khrisna, R A Nugraha, T S Putra, A R Shahab, H Andrianto, I H Kikuko, A N Puspitasari, M R Hajjrin |
| 267 |
[GO] |
2022―Feb―08 |
Clinical manifestation and impact on management of acute coronary syndrome during covid-19 pandemic, lessons learnt from a tertiary care |
T Subburaja, K A Sambasivam, R Radhika, P Sankara Thiagarajan |
| 268 |
[GO] |
2022―Feb―08 |
Impact of the COVID-19 pandemic on cardiology services in the second year at a South Asian cardiac centre |
F A Cader, M M Haq, S R Khan |
| 269 |
[GO] |
2022―Feb―08 |
Early impact of COVID-19 pandemic on heart transplant volumes in Asia and Oceania: results from the Global Observatory on Donation and Transplantation (GODT) |
Y Manla, N Bader, G Bajwa, L Gobolos, F Alsindi, I Hamour, H Ghalib, F Al Badarin |
| 270 |
[GO] |
2022―Feb―08 |
Correlation of cardiac biomarkers with computed tomography severity score in COVID-19 patients |
R Rivera, L Cuenza, T Razon-Cuenza |
| 271 |
[GO] |
2022―Feb―08 |
Anticoagulation practices and venous thromboembolism in COVID-19 patients in a Philippine tertiary hospital |
M Ramos |
| 272 |
[GO] |
2022―Feb―08 |
Thromboembolic complication among COVID-19 patients in the intensive care unit (ICU): a single-centre study from a Malaysian perspective |
H Zulkifly, F Mansor, I Abdul Halim Zaki, K S Eng, L C Kiok, T Ravi, M Pathmanathan, S Abd Wahab, R Muda |
| 273 |
[GO] |
2022―Feb―08 |
Efficacy and safety of fondaparinux versus unfractionated heparin in patients hospitalised with severe COVID-19 pneumonia and coagulopathy: a randomised, open-label clinical trial |
L H Adrian, S A Hutomo, A D S Negari |
| 274 |
[GO] |
2022―Feb―08 |
Prevalence and predictors for high blood pressure during covid-19 vaccination in Thailand |
S Patamatamkul |
| 275 |
[GO] |
2022―Feb―08 |
Evaluation of outcome of Coronavirus disease 2019 patients receiving RAAS inhibitors (OCRAS study): a prospective observational study of Bangladeshi hypertensive patients |
A B D Majumder, M T Rahman, A K M Islam, M Ullah, M K Zaman, M A Reza, M S Islam, R C Khan, M Z Rahman, M M Rahman, M A Awal, S Kabir, G K Paul, S Nasrin, S Zaman |
| 276 |
[GO] |
2022―Feb―08 |
Impact of SARS-CoV2 pandemic onto acute ST-elevation myocardial infarction care and patient outcomes in a large tertiary cardiac center |
D Yong, M A Sulong, M Sundarajoo, N Am Haris, M Y Low, K Kaniappan, A A Nuruddin |
| 277 |
[GO] |
2022―Feb―08 |
The role of STEMI integrated networking system based on tele-cardiology for reducing ischemic time and crossing wire time delayed during COVID 19 pandemic |
M Rizki Fadlan, S Anjarwani, M Saifur Rohman |
| 278 |
[GO] |
2022―Feb―08 |
A survey-based comparison of cardiovascular health risk behaviours in Indian men and women during the pandemic |
P Chockalingam, V Natarajan, T Sekar |
| 279 |
[GO] |
2021―Dez―31 |
Frequency and outcome of acute coronary syndrome during the Covid-19 pandemic |
R A Mousavi, C Wallmueller, P Stratil, G Pichler, F Piringer, G Delle Karth, A Schober |
| 280 |
[GO] |
2021―Dez―20 |
Corrigendum to: European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis; and ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up |
|
| 281 |
[GO] |
2021―Okt―25 |
Impact of COVID-19 on angioplasty service and outcome of patients treated for critical limb ischaemia |
A Rodway, C Giltinan, A Dehghan-Nayeri, A Santos, M Stafford, M B Whyte, C Allan, B Field, J Clark, F Pazos Casal, A Pankhania, T Loosemore, C Heiss |
| 282 |
[GO] |
2021―Okt―22 |
Myocardial infarction versus COVID-19 blood secretome |
V F Sadykov, A A Bogdanova, A A Sergeev, M V Konovalova, E Konstantinova, A V Pyregov, R A Poltavtseva, M Y Gilyarov, E V Svirshchevskaya |
| 283 |
[GO] |
2021―Okt―22 |
Automated processing of thermal imaging to detect COVID-19 and microvascular dysfunction |
R Y Brzezinski, N Rabin, N Lewis, R Peled, A Tsur, A Kerpel, E M Marom, S Shenhar-Tsarfaty, N Naftali-Shani, G Rahav, E M Grossman, Y Zimmer, Z Ovadia-Blechman, J Leor, O Hoffer |
| 284 |
[GO] |
2021―Okt―22 |
Bromodomain and extraterminal (BET) protein inhibitor, apabetalone, reduces ACE2 expression and attenuates SARS-CoV-2 infection in vitro |
D Gilham, A L Smith, L Fu, D Y Moore, A Muralidharan, S P M Reid, S C Stotz, J O Johansson, M Sweeney, N C W Wong, D El-Gamal, E Kulikowski |
| 285 |
[GO] |
2021―Okt―21 |
Stroke mechanisms associated with coronavirus disease (COVID-19) |
M Kruchinina, A A Gromov, V M Generalov, A V Rabko, V N Kruchinin |
| 286 |
[GO] |
2021―Okt―21 |
Echocardiogram in critically ill patients with COVID-19 |
B F O Gomes, T M B Silva, I R R Menezes, A S Azevedo, L S Peres, D F P Pereira, G P Dutra, S A M Paula, B F S Mendes, J H P Nascimento, A L Cantisano, J L F Petriz, P R Carmo Junior, B B Pereira, G M M Oliveira |
| 287 |
[GO] |
2021―Okt―21 |
Impact of high cardiovascular risk on hospital mortality in patients admitted to intensive care by COVID-19 |
B F O Gomes, T M B Silva, G P Dutra, A S Azevedo, D F P Pereira, L S Peres, J H P Nascimento, J L F Petriz, P R Carmo Junior, B B Pereira, G M M Oliveira |
| 288 |
[GO] |
2021―Okt―21 |
COVID-19 infection impact on cardiovascular and thrombotic events during acute phase and medium-term of the disease |
A Varela Lopez, L Diaz Argueso, C Broco Fernandez, C E Cacho Antonio, P J Antunez Muinos, O Otero Garcia, V Jimenez Ramons, T Gonzalez Ferreiro, M Perez-Poza, M Bastos Fernandez, A Garcia Campos, A Varela Roman, J Lopez Pais, D Lopez Otero, J R Gonzalez Juanatey |
| 289 |
[GO] |
2021―Okt―21 |
Introduction of alternative rehabilitation method for the patients with cardiovascular diseases in conditions of the COVID-19 pandemic |
R V Nesterak, I P Vakaliuk, N V Yakymchyk, I Drapchak, N V Savchuk, V I Sovtus, R S Grygoryshyn, S M Bardashevska |
| 290 |
[GO] |
2021―Okt―21 |
Cardiovascular evaluation with exercise testing using face mask during the COVID-19 pandemic |
H Ilarraza-Lomeli, J Rojano-Castillo, G Carazo-Vargas, P S Flores-Carrillo, C F Barrera-Ramirez, M D Rius-Suarez, H N Ortega-Aranda |
| 291 |
[GO] |
2021―Okt―21 |
The direct and indirect effect of the COVID-19 pandemic on patients with cardiomyopathy |
D J Hammersley, R J Buchan, L Mach, R E Jones, B P Halliday, S K Prasad, A Roberts, J S Ware |
| 292 |
[GO] |
2021―Okt―21 |
Impact of COVID-19 pandemic on surgical care of patients with acute aortic conditions |
X Yuan, U Rosendahl, G Asimakopoulos, C Quarto, B Rosser, J Gaer, M Petrou, S Bhudia, T Bahrami, C Nienaber |
| 293 |
[GO] |
2021―Okt―21 |
Cardiopulmonary exercise testing in COVID-19 patients at 3 months follow-up |
V De Marzo, P Clavario, R Lotti, C Barbara, A Porcile, G Guglielmi, C Russo, A J Autala, R Griffo, G Parati, U Corra', I Porto |
| 294 |
[GO] |
2021―Okt―21 |
Clinical outcomes in COVID-19 patients with in-hospital cardiac arrest - an insight from multi-centre data |
M Mughal, I Kaur, S Waxman, H Gandhi, M Kakadia, Z Khakwani, A Okoh, K Shah, A Obaid, V Sirpal, S Azad, A Jaffery, H Jagdey, I Tawfik, M Alam |
| 295 |
[GO] |
2021―Okt―21 |
Are there any long-term cardio-pulmonary limitations of hospitalized Covid-19 patients? |
R Badr Eslam, C Binder-Rodriguez, A Iscel, J Niebauer, R A Mousavi, C Kronberger, C Wenisch, D Bonderman |
| 296 |
[GO] |
2021―Okt―21 |
Comparison of echocardiographic parameters of patients with COVID-19 pneumonia in hospital and three months after discharge |
E Yaroslavskaya, D Krinochkin, N Shirokov, E Gultyaeva, V Garanina, A Mamarina, N Osokina, E Gorbatenko, N Musikhina, T Petelina |
| 297 |
[GO] |
2021―Okt―21 |
Critical COVID-19 rarely associated with left ventricular systolic impairment |
E Nakou, R Fisher, C Tountas, E Corcoran, A Dhariwal, A Marvaki, A Hua, K O'Gallagher, A Nabeebaccus, P Pearson, T Fonseca, A Osborne, C Vega, M Monaghan, A Papachristidis |
| 298 |
[GO] |
2021―Okt―21 |
Frequent constriction-like echocardiographic findings in elite athletes following mild COVID-19: in the grasp of SARS-CoV-2? |
B K Lakatos, M Tokodi, A Fabian, Z Ladanyi, Z Eles, V Juhasz, H Vago, N Sydo, E Csulak, A R Kiss, M Horvath, Z Gregor, O Kiss, B Merkely, A Kovacs |
| 299 |
[GO] |
2021―Okt―21 |
Impact of the first coronavirus-disease pandemic wave on cardiovascular admissions and sudden cardiac death rates in Greece |
E Pagourelias, V P Vassilikos, K Katsos, E Zaggelidou, N Raikos, S Tzikas, C Tsavousoglou, A Kouparanis, A Anastasakis, G Kassimis, A Ziakas, G Sianos, H Karvounis, I Kanonidis, C Spiliopoulou |
| 300 |
[GO] |
2021―Okt―21 |
Myocardial injury in patients hospitalized for SARS-CoV19: a maker or a marker of prognosis? |
C Montalto, S Ghio, M Pagnesi, A Cappelletti, L Baldetti, E Baldi, C Lombardi, L Lupi, M Metra, S Perlini, L Oltrona-Visconti |
| 301 |
[GO] |
2021―Okt―21 |
Discriminatory accuracy of the SOFA score for determining clinical decompensation in patients presenting with COVID-19 |
N Krepostman, M Collins, K Merchant, S De Sirkar, L Chan, S Allen, J Newman, D Patel, J Fareed, S Berg, A Darki |
| 302 |
[GO] |
2021―Okt―21 |
Prehospital period in patients with COVID-19 and community acquired pneumonia: age characteristics, cardiovascular comorbidity and pharmacotherapy during epidemic wave (the data of hospital registry) |
M Lukiyanov, S Y Martsevich, A A Pulin, N P Kutishenko, E Y Andreenko, V A Dindikova, A N Makoveeva, E Y Okshina, N A Dmitrieva, O V Lerman, V P Voronina, A V Zagrebelnyy, V G Klyashtorny, O E Karpov, O M Drapkina |
| 303 |
[GO] |
2021―Okt―21 |
Echocardiography and ECG monitoring not very beneficial in COVID-19 follow-up even in long haulers |
M Radvan, M Kamenik, L Koc, E Bartecku, L Sykorova, P Kala |
| 304 |
[GO] |
2021―Okt―21 |
Predictors of clinical decompensation in patients presenting with COVID-19 in an urban hospital health system |
N Krepostman, M Collins, K Merchant, S De Sirkar, L Chan, S Allen, J Newman, D Patel, J Fareed, S Berg, A Darki |
| 305 |
[GO] |
2021―Okt―21 |
COVID-19 in pregnant women with heart diseases. Adverse maternal and fetal outcomes. Case series from InCor registry of Pregnancy and Heart Disease |
M R Kirschbaum, M S Devido, E Azeka, L M M F Demarchi, J S Santos, D V R Pinto, L A Hajjar, F Tarasoutchi, M Park, W S Avila |
| 306 |
[GO] |
2021―Okt―21 |
Structure and predictors of repolarization disorders in patients with severe COVID-19 infection |
T D Danilevych, Y M Mostovoy, L V Rasputina |
| 307 |
[GO] |
2021―Okt―21 |
Closure of outpatient cardiac rehabilitation during the first COVID-19 lockdown in Austria in spring 2020 resulted in deteriorating physical exercise capacity: a mixed-methods study |
S T Kulnik, M Sareban, I Hoeppchen, S Droese, A Egger, J Gutenberg, B Mayr, B Reich, D Wurhofer, J Niebauer |
| 308 |
[GO] |
2021―Okt―21 |
Levels of hypersensitive troponin T in the emergency department as a predictive factor of mortality for hospitalized COVID-19 patients |
Y P Pionnier, P D Denoel, A M Manara, K Brousmiche |
| 309 |
[GO] |
2021―Okt―21 |
Assessment of vascular endothelial function in COVID-19 patients |
H Mejia-Renteria, A Travieso, A Sagir, E Martinez-Gomez, A Carrascosa-Granada, I Nunez-Gil, V Estrada, A Lerman, J Escaned |
| 310 |
[GO] |
2021―Okt―21 |
Previous psychiatric disorders and antipsychotic drugs in COVID-19 patients: early findings on possible worse outcome |
M Scarpone, M Bergami, E Cenko, R Bugiardini, E Poluzzi, O Manfrini |
| 311 |
[GO] |
2021―Okt―21 |
Psychological profile of COVID-19 pneumonia survivors three month after hospitalization |
E Yaroslavskaya, O Guskova, B Prilenskii, T Petelina |
| 312 |
[GO] |
2021―Okt―21 |
Laboratory indicators of inflammation and systolic function of the left and right ventricles in patients with cardiovascular disease who have undergone COVID-19-associated pneumonia |
N Musikhina, T Petelina, E Yaroslavskaya, D Krinochkin, N Shirokov, N Osokina, E Gorbatenko |
| 313 |
[GO] |
2021―Okt―21 |
Obesity strongly predicts COVID-19-related major clinical adverse events in Coptic Clergy |
M Y Henein, I Bytyci, R Nicoll, S Rafik, S Ayad, F Vanchari |
| 314 |
[GO] |
2021―Okt―21 |
Interventional cardiology in times of COVID-19: impact on a terciary centre |
A Azul Freitas, C Ferreira, S Martinho, V Goncalves, J Almeida, J Rosa, G Campos, E Jorge, L Goncalves |
| 315 |
[GO] |
2021―Okt―21 |
Effect of body mass index on cardiac injury/cardiovascular outcomes in coronavirus disease 2019: a systematic review and meta-analysis |
M Ashraf, V Zlochiver, M S Rawala, M Dahar, J Robinson, M F Jan |
| 316 |
[GO] |
2021―Okt―21 |
Cardiac troponin as major mortality risk factor in SARS-CoV-2 infection |
A Gonzalez Leal, S Antonana Ugalde, A Arteagoitia Bolumburu, J M Monteagudo Ruiz, R R Martinez Moya, R Ortega Perez, S Rivas Garcia, M A Sanroman Guerrero, A Lorente Ros, L M Rincon Diaz, J L Zamorano Gomez |
| 317 |
[GO] |
2021―Okt―21 |
SARS-CoV2 infection: functional and morphological cardiopulmonary changes in elite handball players |
S Fikenzer, A Kogel, P Hepp, D Lavall, S T Stoebe, U Rudolph, U Laufs, A Hagendorff |
| 318 |
[GO] |
2021―Okt―21 |
The impact of anxiety level on medical decisions of non-COVID patients during the pandemic outbreak |
O Koren, S Abu Rajab, M Barbour, M Shachar, A Shahar, K Zubidat, W Slim, D Igbariya, E Rozner, Y Turgeman, E Mader |
| 319 |
[GO] |
2021―Okt―21 |
Patterns of cardiac involvement in patients with long COVID syndrome using cardiovascular magnetic resonance |
V Puntmann, S Martin, B Vanchin, N Holm, E Giokoglu, J Hoffmann, A Karyou, C Arendt, Y Khodamoradi, M Vehreschild, A Braner, G Rohde, A Zeiher, T Vogl, E Nagel |
| 320 |
[GO] |
2021―Okt―21 |
Prognostic value of myocardial injury biomarker in COVID-19: a systematic review and meta-analysis |
S Chen, E Marcella, J Tandiono, R Heriyanto, C Jonatan, A Kurniawan |
| 321 |
[GO] |
2021―Okt―21 |
Compelled dichotomy of the cardiology training during COVID-19 time: green flag to the distant technologies |
G Neplueva, S Soloveva, O Irtyuga, V Zaitsev, L Korostovtseva, S Villevalde, E Parmon |
| 322 |
[GO] |
2021―Okt―21 |
Effects of COVID-19 pandemic on cardiac surgery and practice. Did we hit the mark: strategy or casuality? |
M Di Gaetano, A S Minotti, F Usai, E Morini, M L Contristano |
| 323 |
[GO] |
2021―Okt―21 |
Implementation of a remote rapid access chest pain service during the COVID-19 pandemic |
N Wijesuriya, H Butt, C Davis, S Jodar, M Hayes, T Lockie |
| 324 |
[GO] |
2021―Okt―21 |
Prevalence of dyspnea and/or chest pain persistence at mid-term after COVID-19 infection: a systematic review and meta-analysis |
H Mustafic, D Cekovic, Y Yordanov, A Dinh, G Helft, P Jourdain |
| 325 |
[GO] |
2021―Okt―21 |
Obesity and COVID-19 in the octogenarians |
M Scarpone, M Bergami, M Cenko, R Bugiardini, O Manfrini |
| 326 |
[GO] |
2021―Okt―21 |
Antihypertensive medication and outcome in patients with COVID-19 compared to non-COVID respiratory infections |
S Blum, M Lampart, Q Zhou, C Mueller, S Osswald, G M Kuster, R Twerenbold |
| 327 |
[GO] |
2021―Okt―21 |
The predictive value of cardiac biomarkers and echocardiography in critical COVID-19 |
S Dhont, B Zwaenepoel, E Hoste, F Tromp, E Vandecasteele, S Gevaert, H Schaubroeck |
| 328 |
[GO] |
2021―Okt―20 |
Cardiac arrhythmias 3 months after hospitalization for COVID-19 |
C B Ingul, J Grimsmo, A Mecinaj, D Trebinjac, M Berger Nossen, S Andrup, K Stavem, T Josefsen, T Omland, T Jensen |
| 329 |
[GO] |
2021―Okt―20 |
Impact of the COVID-19 pandemic on emergent pacemaker implantation during lockdown and its aftermath |
D De Almeida Fernandes, R Cadete, J Guimaraes, E Monteiro, G Costa, N Antonio, L Goncalves |
| 330 |
[GO] |
2021―Okt―20 |
Prognostic significance of cardiac injury in COVID-19 patients with and without coronary artery disease |
H Barman, A Atici, H O Arabaci, I Sahin, B Gungor, S M Dogan |
| 331 |
[GO] |
2021―Okt―20 |
Thrombosis in peripheral artery disease and thrombotic thrombocytopenia after adenoviral COVID-19 vaccination |
Filippo Crea |
| 332 |
[GO] |
2021―Okt―20 |
Impact of COVID-19 in adult patients with congenital heart disease |
I Cardoso, T B Branco, A Constante, J Martins, L Sousa, J Viegas, T Rito, R C Ferreira |
| 333 |
[GO] |
2021―Okt―20 |
The impact of the COVID-19 pandemic on the management and outcomes of STEMI patients in Switzerland |
S Fournier, T Mahendiran, D Radovanovic, G Pedrazzini, F Eberli, M Roffi, R Kobza, H Rickli |
| 334 |
[GO] |
2021―Okt―20 |
Comparison of D-dimer level measured on the third day of hospitalization with D-dimer level in predicting in-hospital mortality in COVID-19 patients |
M Selcuk, T Cinar, N Gunay, M Keskin, V Cicek, S Kilic, S Asal, A L Orhan |
| 335 |
[GO] |
2021―Okt―20 |
Modified CHA2DS2-VASc can predict mortality in COVID-19 patients admitted to the emergency department |
B V Silva, C Jorge, C Mendonca, M L Urbano, T Rodrigues, P Silverio Antonio, J Brito, P Alves Da Silva, B Garcia, C Martins, J Rigueira, I Ricardo Aguiar, M Nobre Menezes, R Placido, F J Pinto |
| 336 |
[GO] |
2021―Okt―20 |
Cardiac biomarkers as prognosticators among SARS-CoV-19 patients in a tertiary hospital in Philippines |
R Ong, C Chacon, S Javier |
| 337 |
[GO] |
2021―Okt―20 |
Impact of type 2 diabetes mellitus on clinical outcomes in patients with COVID-19 and cardiovascular disease |
K G Lobanova, T Y U Demidova, V M Plakhotnyaya |
| 338 |
[GO] |
2021―Okt―20 |
Outcomes of COVID-19 infection in heart transplant recipients |
D Miklin, A Mantha, A Wolfson, A Vaidya, E Depasquale |
| 339 |
[GO] |
2021―Okt―20 |
Impact of COVID-19 lockdown on the procedural and intra-hospital outcome of STEMI patients |
L Gaede, H Rittger, H Gerrens, A Achajew, N Schacher, P Ferstl, M Troebs, M Arnold, M Marwan, S Achenbach |
| 340 |
[GO] |
2021―Okt―20 |
Impact of COVID-19 on heart failure hospitalizations: one year after |
R Gonzalez-Manzanares, G Heredia Campos, C Fernandez-Aviles Irache, A Resua Collazo, C Pericet-Rodriguez, I Gallo-Fernandez, A Fernandez-Ruiz, L Carnero Montoro, M.J Oneto-Fernandez, A Luque-Moreno, N Paredes-Hurtado, D Pastor-Wulf, J Lopez-Baizan, J.C Castillo-Dominguez, M Anguita |
| 341 |
[GO] |
2021―Okt―20 |
Prehospital ECG in patients with acute myocardial infarction during the COVID-19 pandemic |
M Avvedimento, A Leone, A Spinelli, A Franzone, G Esposito, R Piccolo |
| 342 |
[GO] |
2021―Okt―20 |
Impact of telehealth in the outpatient management of atrial fibrillation during the COVID-19 pandemic |
I Shatla, Y Sammour, K Kennedy, A P Wimmer |
| 343 |
[GO] |
2021―Okt―20 |
COVID-19 pandemic and admission rates for and management of acute coronary syndromes in Israel |
E Asher, A Fardman, D Zahger, K Orvin, M Mohsen, O Tsafrir, R Rubinshtein, J Jamal, R Efraim, N Kofman, M Halabi, Y Shacham, L Henri Fortis, R Beigel, S Matetzky |
| 344 |
[GO] |
2021―Okt―20 |
Indirect effects of COVID-19 Pandemic in ST-segment elevation myocardial infarction: insights from a multicentric national survey |
H Pereira, R Cale, P Farto-Abreu, E Pereira, S S L On Behalf Of Stent Save A Life Initiative |
| 345 |
[GO] |
2021―Okt―20 |
Effects of remote monitoring of patients with heart failure based on smartphone application in the context of the COVID-19 pandemic in the Kyrgyz Republic |
A R Rustambekova, M R Djusupbekova, A A Moldobaeva, A I Moldomamatova, A M Noruzbaeva |
| 346 |
[GO] |
2021―Okt―20 |
Impact of the Covid-19 pandemic on the device therapy for patients with the heart failure |
R Hall, R Chattopadhyay, P.J Pugh |
| 347 |
[GO] |
2021―Okt―20 |
In-hospital predictors of 60-day readmission in COVID-19 patients |
M Ruge, A Gill, J M D Gomez, J Du Fay De Lavallaz, J A Simmons, K A Williams, A S Volgman, K Marinescu, A Rao, T Suboc |
| 348 |
[GO] |
2021―Okt―20 |
The impact of daily troponin-I and D-dimer serum levels on mortality of moderate-to-severe COVID-19 pneumonia patients |
B Stavileci, E Ozdemir |
| 349 |
[GO] |
2021―Okt―20 |
Prognostic significance of N-Terminal Pro-BNP in patients with COVID-19 pneumonia without previous history of heart failure |
M Selcuk, M Keskin, T Cinar, N Gunay, S Dogan, V Cicek, S Kilic, S Asal, S Yavuz, N Keser, A.L Orhan |
| 350 |
[GO] |
2021―Okt―20 |
Three-month cardiac outcomes of survivors of COVID-19 presenting to a district general hospital in West Hertfordshire, UK |
P K Pyae, A Navarra, R Webb, A Newland-Smith, R Vancheeswaran, J Sehmi, A Barlow |
| 351 |
[GO] |
2021―Okt―20 |
Biochemical and cardiovascular predictors of PIMS risk in children after COVID-19 recovery =- the results of the LATE COVID Kids study |
I Jatczak-Pawlik, J Lewek, E Czkwianianc, K Zeman, P Jankowski, M Banach |
| 352 |
[GO] |
2021―Okt―20 |
Hypertension as a prognostic factor in the prediction of mortality in patients with COVID-19: a systematic review and meta-analysis |
C D P Pagdanganan, J Juangco |
| 353 |
[GO] |
2021―Okt―20 |
Role of telemedicine network provided by pharmacies to detect acute myocardial infarction in patients with chest pain during coronavirus pandemia |
F Fioretti, M Piazzani, D S Cani, A Madureri, G F Gensini, F Gabbrielli, G Bollani, F Glisenti, S Nodari |
| 354 |
[GO] |
2021―Okt―20 |
Cardiovascular predictors associated with poor short-term prognosis in patients diagnosed with SARS-CoV-2 in Spain |
L Esteban-Lucia, A Devesa-Arbiol, M A Zambrano Chacon, A M Venegas Rodriguez, M Gonzalez-Rodriguez, L Maure-Blesa, P Avila-Barahona, A M Pello-Lazaro, O Gonzalez-Lorenzo, R Fernandez-Roblas, F Villar-Alvarez, B Ibanez, J Tunon, A Acena Navarro, J A Franco Pelaez |
| 355 |
[GO] |
2021―Okt―20 |
The surgical management of heart failure: heart transplantation in the era of SARS-CoV-2 pandemic |
J Malyszek, M Jasinska, M Zembala, K Ratman, B Krol, K Tkocz, K Pelar, P Sybila, M Pajor, Z Nawrat |
| 356 |
[GO] |
2021―Okt―20 |
Sars-CoV2- infection as a trigger of humoral response against apolipoprotein A-1 |
S Pagano, S Yerly, N Suh, C Le Terrier, L Farrera-Soler, G Piumatti, C S Eberhardt, C A Siegrist, I Eckerle, S Stringhini, I Guessous, L Kaiser, J Pugin, N Winssinger, N Vuilleumier |
| 357 |
[GO] |
2021―Okt―20 |
Post-COVID myocarditis diagnosed by endomyocardial biopsy and/or magnetic resonance imaging 2-9 months after acute COVID-19 |
O Blagova, D H Ainetdinova, Y U A Lutokhina, V M Novosadov, R S Rud', A Y U Zaitsev, A D Kukleva, S A Alexandrova, E A Kogan |
| 358 |
[GO] |
2021―Okt―20 |
Atrial fibrillation is associated with poor clinical trajectory of COVID-19 |
S.J Stjepan Jurisic, M.K Komminoth, B.W Wiggli, D.A.B Bertschi, P.K Koepfli, I.V Vranjic, A.F Friedl, J.C Contartese, F.F Fontana, H.S Schmid, J.R Rutishauser, C.G Gebhard, A.T Todorov, J.B Beer, D Patriki |
| 359 |
[GO] |
2021―Okt―20 |
Cardiovascular outcomes in hospitalized patients with COVID-19 and history of cancer: a CORONA-VTE analysis |
C D Khairani, B M Barns, S M Rizzo, M B Pfeferman, J E Snyder, S Z Goldhaber, G Piazza |
| 360 |
[GO] |
2021―Okt―20 |
Increased incidence of Persistent Pulmonary Hypertension of the Newborn following third trimester maternal COVID-19 infection |
A Ishqeir, A Nir, I Aptowitzer, M Godfrey |
| 361 |
[GO] |
2021―Okt―20 |
Blood pressure changes during the the COVID-19 pandemic and associated lockdown period |
N Girerd, C Meune, K Duarte, V Vercamer, M Lopez-Sublet, J J Mourad |
| 362 |
[GO] |
2021―Okt―20 |
Combined cardiac risk factors predict COVID-19 related mortality and the need for mechanical ventilation in Coptic Clergy |
M Y Henein, I Bytyci, R Nicoll, R Sheneuda, S Ayad, M Cameli, F Vancheri |
| 363 |
[GO] |
2021―Okt―20 |
Meta-Analysis of COVID-19 treatments on patients with a previous diagnosis of cardiovascular disease |
S Ben-Aicha, J Buchanan, M Moscarelli, P Punjabi, C Emanueli |
| 364 |
[GO] |
2021―Okt―20 |
Myocardial ischaemia of non-obstructive origin as a cause of new onset anginal chest pain in the long COVID syndrome |
C Espejo, H Mejia-Renteria, A Travieso, N Gonzalo, S Fernandez, M L Capote, O Vedia, L Wang, I Nunez-Gil, J M Grande Ingelmo, I Fernandez Rozas, C Olmos, D Vivas, J Escaned |
| 365 |
[GO] |
2021―Okt―20 |
Early experience utilizing bivalirudin as anticoagulation in extracorporeal membrane oxygen in coronavirus disease 2019 |
C X J Jones, K C Chen, C T Tejera, R R Reddy, C F Faber, S M Mirza, W G Ghumman, V N Rarendran, R C Chait |
| 366 |
[GO] |
2021―Okt―20 |
Early detection of exacerbation of the severe acute respiratory syndrome coronavirus 2 infection using Fitbit (DEXTERITY pilot study) |
K Yamagami, A Nomura, M Kometani, M Shimojima, K Sakata, S Usui, K Furukawa, M Takamura, M Okajima, K Watanabe, T Yoneda |
| 367 |
[GO] |
2021―Okt―20 |
Myocardial involvement in COVID-19: data from 102 unselected autopsies during the first wave of pandemic |
P Platonov, V V Vasilyev, G Startseva, V E Karev, M G Rybakova, E S Romanova |
| 368 |
[GO] |
2021―Okt―20 |
Immature platelets in patients with Covid-19: association with disease severity |
E Harari, A Cohen, M Cipok, G Bryk, N Karp Lador, T Mann, A Mayo, E I Lev |
| 369 |
[GO] |
2021―Okt―20 |
Effect of statins on mortality in patients with COVID-19: an updated meta-analysis of 147824 patients |
C Diaz-Arocutipa, B Melgar-Talavera, M Saravia-Bartra, P Cazorla, I Belzusarri, A Alvarado-Yarasca, A V Hernandez |
| 370 |
[GO] |
2021―Okt―20 |
Sustained endothelial, coagulation and inflammatory cytokine activation without macrovascular dysfunction at 3 months after COVID-19: a reflection on SARS-CoV-2 induced thrombo-inflammation |
L H Willems, M Nagy, H Ten Cate, H M H Spronk, L A Groh, J Leentjes, N A F Janssen, M G Netea, D H J Thijssen, G J Hannink, A S Van Petersen, M C Warle |
| 371 |
[GO] |
2021―Okt―20 |
Increased risk of COVID-19-associated death in people under 70 with cardiovascular disease compared to the general population- A nationwide, registry-based study from Norway |
R B Forster, T.Å Myklebust, K M Gravningen, R Kvale |
| 372 |
[GO] |
2021―Okt―20 |
Antiplatelet therapy and outcome in patients with COVID-19. Results from a multi-center international prospective registry (HOPE-COVID19) |
F Santoro, E Vitale, I Nunez Gil, F Guerra, I El-Battrawy, N D Brunetti |
| 373 |
[GO] |
2021―Okt―20 |
Impact of SARS-CoV-2 pandemic in a phase II cardiac rehabilitation programme: looking back |
R Soria Navarro, L Tojal Sierra, I Juanes Dominguez, E Saez De Buruaga Corrales, E Virosta Gil, M J Apodaca Arrizabalaga, A Beltran De Guevara Sainz Pardo, E Gomez Corcuera, C Manzabal Gonzalez, Z Fernandez Fernandez De Leceta, E Para Barbero, M Pasalodos Heras, A Cortes Urruchi, A M Alonso Gomez, M C Bello Mora |
| 374 |
[GO] |
2021―Okt―20 |
Telmisartan for treatment of Covid-19 patients: an open randomized clinical trial |
M Duarte, F Pelorosso, L N Nicolosi, V Salgado, H M Vetulli, A Arquieri, F Azzato, J Coyle, I Davolos, I Fernandez Criado, R Gregori, M C Rubio, S M Sarquis, F Whalmann, R P Rothlin |
| 375 |
[GO] |
2021―Okt―20 |
Implications of left ventricular function on short-term outcomes in COVID-19 patients with myocardial injury |
G Medranda, B C Case, H Rappaport, C Zhang, C Yerasi, B J Forrestal, C Chezar-Azzerad, W S Weintraub, R Waksman |
| 376 |
[GO] |
2021―Okt―20 |
Cardiopulmonary examinations of athletes returning to high-intensity sport activity following SARS-CoV-2 infection |
O Kiss, M Babity, A Konig, M Zamodics, Z S Gregor, M Horvath, A Kiss, R Rakoczi, V Juhasz, Z S Dohy, L Szabo, B Lakatos, A Kovacs, H Vago, B Merkely |
| 377 |
[GO] |
2021―Okt―20 |
Effect of prophylactic and therapeutic low molecular weight heparins on mortality in 15,704 COVID-19 patients. A systematic review and a meta-analysis |
A Pani, R Giossi, D Menichelli, E Tratta, A Romandini, R Roncato, A Nani, P Schenardi, E Diani, V A Fittipaldo, A Farcomeni, F Scaglione, D Pastori |
| 378 |
[GO] |
2021―Okt―20 |
Correlation of peripheral pulse wave features and pulse rate variability parameters with hospitalization of COVID-19 patients - the scientific aspect of a tele-pulse oximetry project study design |
D Kulin, F Antali, S Kulin, K Dozsa, S Bekassy, Z Miklos |
| 379 |
[GO] |
2021―Okt―20 |
Development and validation of the ABC2-SPH risk score for in-hospital mortality in COVID-19 patients |
M Marcolino, M C Pires, L E F Ramos, R T Silva, L M Oliveira, R L R Carvalho, L S Monteiro, M V R Souza-Silva, T L S Sales, K P M P Martins, I J Borges Do Nascimento, A Sanchez-Montalva, B Raventos, E Boersma, C A Polanczyk |
| 380 |
[GO] |
2021―Okt―20 |
Mean serum D-dimer level to predict in-hospital mortality in Covid-19 patients |
M I Hayiroglu, V Cicek, S Kilic, T Cinar |
| 381 |
[GO] |
2021―Okt―20 |
Incidence and course of acute coronary syndromes cases following first wave of COVID-19 pandemy |
J Jankowska - Sanetra, K Sanetra, M Konopko, M Kutowicz, M Synak, M Kachel, P E Kazmierczak, K Milewski, P P Buszman |
| 382 |
[GO] |
2021―Okt―20 |
The prevalence and characteristics of patients with ST-elevation myocardial infarction during the first two months of the COVID-19 pandemics |
Y Steinmetz, R Wolff, R Farkash, Z Dadon, N Levi, F Anguizola, L Taha, F Shaheen, M Glikson, E Asher |
| 383 |
[GO] |
2021―Okt―20 |
Implementation of cardiology tele-visits after COVID-19 pandemic: the INFO-COVID survey |
G Boriani, A Maisano, N Bonini, A Albini, J F Imberti, A Venturelli, G Camaioni, M Passiatore, G De Mitri, G Nanni, D Girolami, V Siena, D Sgreccia, A C Valenti, M Vitolo |
| 384 |
[GO] |
2021―Okt―20 |
The coronavirus disease 2019 pandemic among adult congenital heart disease patients: findings of a one-year multicentric, international study |
F J Ruperti Repilado, M Greutmann, J Bouchardy, P Brennan, L Campens, P Gallego, R Garcia-Orta, A S Jensen, M Ladouceur, B Miranda-Barrio, M Morissens, J Rueda Soriano, A E Van Den Bosch, D Tobler, M Schwerzmann |
| 385 |
[GO] |
2021―Okt―20 |
The impact of the COVID-19 pandemic on transcatheter aortic valve implantation (TAVI) service: a United Kingdom tertiary centre experience |
J H Tan, T K Teoh, J Ivanova, S Jadhav, R Varcoe, K Baig, A Gunarathne |
| 386 |
[GO] |
2021―Okt―20 |
Impact of COVID-19 pandemic on ST-elevation myocardial infarction: data from two Portuguese centers |
L Oliveira, R Campante Teles, C Machado, S Madeira, N Vale, C Almeida, J Brito, S Leal, L Raposo, P Araujo Goncalves, A Pacheco, H Mesquita Gabriel, M Almeida, D Martins, M Mendes |
| 387 |
[GO] |
2021―Okt―20 |
Impact of the COVID-19 pandemic on catheterization laboratory procedural volumes at a tertiary cardiac centre in a low- & middle-income country in South Asia |
F A Cader, I Z Chowdhury, M Z Chowdhury, M M Haq, S R Khan |
| 388 |
[GO] |
2021―Okt―20 |
Impact of the COVID-19 pandemic on cardiology services at a tertiary cardiac centre in a low- and middle-income country in Asia |
F A Cader, I Z Chowdhury, M M Haq, M Z Chowdhury, S R Khan |
| 389 |
[GO] |
2021―Okt―20 |
A telephonic cardiology advice line was effective during the COVID-19 pandemic in both reassuring patients and in ensuring patients received optimal urgent care |
J Devlin, A J Peace, P G McGlinchey |
| 390 |
[GO] |
2021―Okt―20 |
Cardiac and other presentation and clinical outcomes of COVID-19 pandemic among different ethnic and religious populations in the city of Jerusalem |
E Asher, T Samuel, O Yagel, A Wolak, R Farkash, R Durst, E Ben-Chetrit, I Helviz, A Tvito, R Nir-Paz, O Amir, M Glikson |
| 391 |
[GO] |
2021―Okt―20 |
Rapid rollout of a pacemaker home monitoring service during the 2020 COVID-19 pandemic |
J Shurlock, B Gratton, L Wilson, R Heatley, M Roach, M Dayer, G Furniss |
| 392 |
[GO] |
2021―Okt―20 |
Acute coronary syndrome outside and during the COVID-19 pandemic |
A I Maltcev, N A Koriagina, V S Koriagin, K V Prokhorov, G N Spasenkov |
| 393 |
[GO] |
2021―Okt―20 |
The use of telemedicine in cardiogenetics clinical practice during the COVID-19 pandemic |
L Liang, I Kalia, F Latif, M P Waase, G Sayer, M P Reilly, N Uriel |
| 394 |
[GO] |
2021―Okt―20 |
The evolution of management and outcomes of patients with myocardial injury during the COVID-19 pandemic |
B Case, J Abramowitz, C Shea, H Rappaport, C Yerasi, B Forrestal, C Chezar-Azerrad, G Medranda, C Zhang, L Satler, I Ben-Dor, H Hashim, T Rogers, W Weintraub, R Waksman |
| 395 |
[GO] |
2021―Okt―20 |
Triage-HF plus: 12-month study of remote monitoring pathway for triage of heart failure risk initiated during the Covid-19 pandemic |
P Bachtiger, S Park, E Letchford, F Scott, C Barton, F Z Ahmed, G Cole, D Keene, C M Plymen, N S Peters |
| 396 |
[GO] |
2021―Okt―20 |
Left ventricular global longitudinal strain as an indicator of myocardial injury in non-hospitalized COVID-19 survivors |
M Hassan Abdelnabi, H Abdelgawad, Y Saleh, A Almaghraby |
| 397 |
[GO] |
2021―Okt―20 |
The relationship between comorbidities and physical activity and kinesiophobia of patients with heart rhythm disorders in Covid-19 pandemia |
D Saklica, N Vardar-Yagli, Y Z Sener, A H Ates, H Yorgun, K Aytemir |
| 398 |
[GO] |
2021―Okt―20 |
COVID-19 patients with coronary artery disease have a higher mortality risk: a meta-analysis |
M Zuin, G Rigatelli, G Zuliani, L Roncon |
| 399 |
[GO] |
2021―Okt―20 |
Impact of telemedicine network provided by local pharmacies in the management of symptomatic tachyarrhytmias during COVID-19 outbreak |
F Fioretti, M Piazzani, D S Cani, A Madureri, F Gabbrielli, G F Gensini, G Bollani, F Glisenti, S Nodari |
| 400 |
[GO] |
2021―Okt―20 |
Observational study of Covid-19 patients presenting with acute coronary syndrome at a tertiary care center in India |
K Makkar, T S Malhi, A Batta, P Panda, Y P Sharma |
| 401 |
[GO] |
2021―Okt―20 |
COVID-19 patients present impaired endothelial glycocalyx, vascular dysfunction and myocardial deformation resembling those observed in hypertensives four months after infection |
I Ikonomidis, A Kountouri, A Mitrakou, J Thymis, K Katogiannis, E Korakas, C Varlamos, A Bamias, K Thomas, I Andeadou, M Tsoumani, D Kavatha, A Antoniadou, M.A Dimopoulos, V Lambadiari |
| 402 |
[GO] |
2021―Okt―20 |
Short and medium-term impact of a cardiac rehabilitation (CR) program in COVID-19 patients after acute care hospitalization |
E Venturini, A Virgillitto, L Briscese, P Cavicchioli, M Bavera, F Mussini, S Santini, M Bresci, C Laddaga |
| 403 |
[GO] |
2021―Okt―20 |
Impact of COVID-19 pandemics upon pulmonary hypertension patients: insights from BNP-PL national database |
A Mamzer, J D Kasprzak, M Waligora, M Kurzyna, E Mroczek, T Mularek-Kubzdela, P Pruszczyk, M Gasior, E Lewicka, D Karasek, B Kusmierczyk-Droszcz, K Mizia-Stec, K Ptaszynska-Kopczynska, W Jachec, G Kopec |
| 404 |
[GO] |
2021―Okt―20 |
The global effect of Covid-19 on acute coronary syndromes management |
M Lunardi, D Mylotte, P Serruys, W Wijns |
| 405 |
[GO] |
2021―Okt―20 |
The management of severe aortic stenosis during the COVID-19 pandemic: an observational study comparing TAVI and SAVR |
M Akhtar, A Shafi, V Khanna, S Mukhopadhyay, K Patel, M Ozkor, A Baumbach, A Mathur, S Kennon, W Awad, M M Mullen |
| 406 |
[GO] |
2021―Okt―20 |
Covid-19 morbidity and outcomes among the patients observed in the pulmonary hypertension reference center |
Y Sirenko, I Zhyvilo, G Radchenko |
| 407 |
[GO] |
2021―Okt―20 |
COVID-19 pandemic triggers acute myocardial infarction, stroke, and out-of-hospital cardiac arrest in non-infected individuals: the final results of the JoCORE study |
I Alhaddad, A Hammoudeh, E Mdanat, H Makhamreh, R Ibdah, M Fakhri, R Tabbalat |
| 408 |
[GO] |
2021―Okt―20 |
Covid-19 pandemic's impact on management of cardiovascular risk factors in a Phase IIIs period of a cardiac rehabilitation program, fact or fiction? |
L Tojal Sierra, R Soria Navarro, I Juanes Dominguez, E Saez De Buruaga, E Virosta Gil, Z Fernandez Fernandez De Leceta, M J Apodaca Arrizabalaga, E Gomez Corcuera, C Manzabal Gonzalez, A I Conde Lagartos, L M Pasalodos Heras, E Para Barbero, M Arana Monte, M C Bello Mora, A M Alonso Gomez |
| 409 |
[GO] |
2021―Okt―20 |
Cardiac rehabilitation in COVID-19 pandemic period |
J C Costa, I Mouici, L Bichon-Treulet, P Nazeyrollas, D Metz |
| 410 |
[GO] |
2021―Okt―20 |
Impact of previous cardiac conditions in prognosis and clinical management of patient with COVID-19 infection |
S Antonana, J M Monteagudo, A Arteagoitia, A Gonzalez, R Ortega, S Rivas, R R Martinez-Moya, M A Sanroman, A Lorente-Ros, L M Rincon, J L Zamorano |
| 411 |
[GO] |
2021―Okt―20 |
Effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the short-term prognosis of COVID-19 infection |
L Esteban-Lucia, M A Zambrano Chacon, A M Venegas Rodriguez, A Devesa-Arbiol, M Gonzalez-Rodriguez, L Maure-Blesa, P Avila-Barahona, A M Pello-Lazaro, O Gonzalez-Lorenzo, A M Kallmeyer-Mayor, R Fernandez-Roblas, F Villar-Alvarez, J Tunon, J A Franco-Pelaez, A Acena Navarro |
| 412 |
[GO] |
2021―Okt―20 |
Prognostic impact of treatment with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the acute phase and medium-term on COVID-19 infected patients |
C Broco-Fernandez, A Varela-Lopez, L Diaz-Argueso, C E Cacho-Antonio, P J Antunez-Muinos, O Otero-Garcia, V Jimenez-Ramons, T Gonzalez-Ferreiro, M Perez-Poza, M Bastos-Fernandez, A Garcia-Campos, J Lopez-Pais, D Lopez-Otero, J R Gonzalez-Juanatey |
| 413 |
[GO] |
2021―Okt―20 |
The effect of the COVID-19 pandemic on heart failure unplanned admission: a single center study |
N A Yusoff, H S R Ong, Y Cao, Y H Huang, T B Ang, H F D Loh, M M Foong, W L Huang, Y Z Oh, Z W Teo, S G S Lee |
| 414 |
[GO] |
2021―Okt―20 |
High sensitivity troponin as a 60-day mortality marker in patients with COVID-19 in intensive care at a Latin American hospital |
J Sprockel, A L Murcia, J M Rincon, Z Santofimio, H M Cardenas, D Hernandez, J E Parra |
| 415 |
[GO] |
2021―Okt―20 |
Impact of COVID-19 pandemic on a developing STEMI care system from a low-middle income country- a prospective observational study |
J Gnanaraj, E Sindhu, M Nandakumaran, R Veeramani, K Kannan, S Anne Princy, M Cecily Mary, M A Arumugam, P Kannan, K Sabapathy, N Swaminathan, G Senthil Kumar, N Nambirajan, T Balasubramanian, J M Ravichandran Edwin |
| 416 |
[GO] |
2021―Okt―20 |
Better outcome with D-dimer guided anticoagulant in hospitalised patients with moderate and severe COVID-19 illness |
M Bolog, E Pacuraru, A Rapa, M Marcvart, G Albu, L Marzan |
| 417 |
[GO] |
2021―Okt―20 |
Continuous monitoring of advanced hemodynamic parameters shows early cardiovascular changes in a cohort of 492 COVID-19 hospitalized patients |
D Nachman, A Eisenkraft, Y Maor, K Constantini, G Goldstein, R Levy, M Halberthal, N A Horowitz, R Golan, E Rosenberg, E Lavon, O Cohen, G Shapira, N Shomron, Y Gepner |
| 418 |
[GO] |
2021―Okt―20 |
HeartLogic algorithm for heart failure monitoring in the era of CoViD-19 pandemic and remote monitoring/telemedicine |
E Ebrille, C Amellone, M.T Lucciola, M Suppo, G Antonacci, F Gotta, M Birolo, E Favro, F Orlando, M Giammaria |
| 419 |
[GO] |
2021―Okt―20 |
Treatment delay and clinical outcomes in patients with ST-elevation myocardial infarction during the COVID-19 pandemic |
T Tokarek, A Dziewierz, K Malinowski, T Rakowski, S Bartus, D Dudek, Z Siudak |
| 420 |
[GO] |
2021―Okt―20 |
Features of chronic heart failure in COVID-19 pandemic |
E Grigoricheva, G.R Gessen |
| 421 |
[GO] |
2021―Okt―20 |
The association of soluble ACE2 change with metabolic health, body composition and proteome dynamics during a weight loss diet intervention: implications for the COVID-19 pandemic |
N Cauwenberghs, M Prunicki, F Sabovcik, D Perelman, K Contrepois, X Li, M P Snyder, K C Nadeau, T Kuznetsova, F Haddad, C D Gardner |
| 422 |
[GO] |
2021―Okt―20 |
Clinical profile and in hospital mortality of invasively managed patients with suspicion of acute coronary syndrome during the COVID-19 pandemic |
B Michalski, J Z Peruga, M Plewka, K Kupczynska, E Szymczyk, J D Kasprzak |
| 423 |
[GO] |
2021―Okt―20 |
Fast track triage for COVID-19 based on a population study: the SODA score |
J Lopez-Pais, D Lopez-Otero, T Gonzalez Ferrero, C Cacho Antonio, P Antunez Muinos, M Perez-Poza, V Jimenez Ramos, M Sestayo Fernandez, M Bastos Fernandez, X Sanmartin Pena, A Varela Roman, M Portela Romero, A Lopez Lago, M A Perez De Juan Romero, J R Gonzalez Juanatey |
| 424 |
[GO] |
2021―Okt―20 |
A prospective evaluation of COVID-19 associated coagulopathy with acute coronary syndrome (ACS) |
I Pescetelli, M Marchetti, P Gomez Rosas, E Sanga, L Russo, F Moretti, D Pellegrini, L Fiocca, P A Canova, A Vassileva, S Gamba, C Verzeroli, A Grosu, G Guagliumi, A Falanga |
| 425 |
[GO] |
2021―Okt―20 |
Glucocorticoids in myocarditis therapy after COVID-19 |
V Kovalenko, E Nesukay, S Cherniuk, R Kirichenko, A Kozliuk, N Titova, E Titov, J Giresh |
| 426 |
[GO] |
2021―Okt―20 |
Mechanisms of myocardial injury and clinical outcomes in patients hospitalised with suspected COVID-19 |
A Bularga, R Wereski, C Taggart, M Lowry, T Singh, K K Lee, A Anand, A S V Shah, D A Ross, M R Perry, M R Dweck, D E Newby, A R Chapman, N L Mills |
| 427 |
[GO] |
2021―Okt―20 |
Calcium channel blockers and beta-blockers could increased mortality of patients with COVID-19 |
L Esteban-Lucia, M A Zambrano Chacon, A M Venegas Rodriguez, A Devesa-Arbiol, M Gonzalez-Rodriguez, L Maure-Blesa, P Avila-Barahona, A M Pello-Lazaro, O Gonzalez-Lorenzo, A M Kallmeyer-Mayor, R Fernandez-Roblas, F Villar-Alvarez, J Tunon, A Acena Navarro, J A Franco-Pelaez |
| 428 |
[GO] |
2021―Okt―20 |
Application of a clinical decision support system to assess the severity of the new coronavirus infection COVID-19 |
D Gavrilov, T Kuznetsova, A Gusev, N Korsakov, R Novitskiy |
| 429 |
[GO] |
2021―Okt―20 |
Platelet reactivity and immature platelets in patients with Covid-19 |
A Cohen, E Harari, M Cipok, G Bryk, N Karp Lador, T Mann, A Mayo, E I Lev |
| 430 |
[GO] |
2021―Okt―20 |
Correlation of chest CT severity score with D-dimer levels in patients with COVID-19 |
A V Inamdar |
| 431 |
[GO] |
2021―Okt―20 |
Major arterial and venous thromboembolic complications in patients with COVID-19 |
N Lalor, A Raffaeli, F Bottini, J L Scapellato, N Banos, L Pezzati, D Intile, F Longo |
| 432 |
[GO] |
2021―Okt―20 |
Impact of COVID-19 lockdowns on STEMI percutaneous interventions |
V Zlochiver, A C Perez Moreno, J Hall, M Hommeida, S Q Allaqaband, T Bajwa, M F Jan |
| 433 |
[GO] |
2021―Okt―20 |
Heart failure as a complication of COVID-19 infection: systematic review and meta-analysis |
M Zuin, G Zuliani, L Roncon, G Rigatelli |
| 434 |
[GO] |
2021―Okt―20 |
Long-term cardiopulmonary effects after Covid-19 infection |
J H Niebauer, C Binder- Rodriguez, A Iscel, S Klenk, R Badr-Eslam, S Cadjo, M Kahr, S Hoffman, S Reiter-Malqvist, R Boeck, C Wenisch, C Krestan, M Lichtenauer, D Bonderman |
| 435 |
[GO] |
2021―Okt―20 |
Syncope: a worrisome presenting symptom during the first wave of COVID-19 in Italy |
E Ebrille, M.T Lucciola, C Amellone, F Orlando, F Lipani, E Ferreri, M Giammaria |
| 436 |
[GO] |
2021―Okt―20 |
Troponin T in COVID-19 hospitalized patients: kinetics matter |
M L Luchian, A I Motoc, S Lochy, J Magne, B Roosens, D Belsack, K Van Den Bussche, B Von Kemp, X Galloo, C E Francois, L Seyler, J Van Laethem, C Weytjens, S Droogmans, B Cosyns |
| 437 |
[GO] |
2021―Okt―20 |
Out-of-hospital cardiac arrest in COVID-19 era. A single center experience |
D Aschieri, M Villani, M Lanati, M.T Didio, V Pellizzoni, G.Q Villani |
| 438 |
[GO] |
2021―Okt―20 |
Cardiopulmonary exercise test in patients with persistent dyspnea after COVID-19 disease |
J Borrego Rodriguez, A Berenguel Senen, C De Cabo Porras, M Gallango Brejano, E Gigante Miravalles, C Morante Perea, A Serrano Blanco, A Gadella Fernandez, A Martinez Camara, P Sanchez-Aguilera Sanchez-Paulete, M Lazaro Salvador, M Flores Hernan, M G Lozano Lazaro, M A Arias Palomares, L Rodriguez Padial |
| 439 |
[GO] |
2021―Okt―20 |
Hospital admissions for acute coronary syndromes during the first SARS-CoV-2 epidemic wave: time course, patients characteristics and in-hospital mortality |
F Orso, G Casolo, S Forni, C Szasz, V Di Fabrizio, F Gemmi |
| 440 |
[GO] |
2021―Okt―20 |
Role of heparin prophylaxis at different doses in patients with COVID-19 and respiratory failure: a systematic review and meta-analysis |
M C Vedovati, M Graziani, C Becattini |
| 441 |
[GO] |
2021―Okt―20 |
Crowding at hospitals- the main reason for not seeking medical care when affected by an acute myocardial infarction during the first wave of COVID-19 |
M Lidin, P Lynga, A Kinch Westerdahl, C Nymark |
| 442 |
[GO] |
2021―Okt―20 |
First-phase ejection fraction, a measure of pre-clinical heart failure, is strongly associated with increased mortality in patients with COVID-19 |
H Gu, C Chiara, A Nabeebaccus, Z Sun, L Fang, Y Xie, L Zhang, G Carr-White, A Shah, M Xie, P Chowienczyk |
| 443 |
[GO] |
2021―Okt―20 |
Soluble urokinase-type plasminogen activator receptor (suPAR) is associated with risk for thromboembolic complications and mortality in patients with COVID-19 |
S Luo, B Samelko, J M Du-Fay-De-Lavallaz, J M D Gomez, A M Zemke, T Suboc, K A Williams, S Fugar, J A Simmons, A S Volgman, S Hayek, J Reiser |
| 444 |
[GO] |
2021―Okt―20 |
Apremilast improves endothelial glycocalyx and microvascular perfusion: a possible protective mechanism against COVID-19 |
I Ikonomidis, G Pavlidis, J Thymis, P Rafouli-Stergiou, G Makavos, G Kostelli, P Katsimbri, V Lambadiari, J Parissis, E Kapniari, K Katogiannis, A Kountouri, E Korakas, K Theodoropoulos, E Papadavid |
| 445 |
[GO] |
2021―Okt―20 |
The growing role of designated communicators in the monitoring of patients with left ventricular assist device in the era of the COVID pandemic |
M Sobieszczanska-Malek, J Szymanski, M Zaleska-Kociecka, B Burczynska, M Kusmierczyk, T Zielinski |
| 446 |
[GO] |
2021―Okt―20 |
How did the first pandemic COVID wave affect acute myocardial infarction hospital assistance? |
A Pacheco, D Carvalho, P Carvalho, L Ferraz, A Briosa, P Bem Haja, M Bastos |
| 447 |
[GO] |
2021―Okt―20 |
Different COVID19 pandemic phases & STEMI: experience from an Italian hub centre |
G Tumminello, L Barbieri, F Toriello, S Lucreziotti, M Carla', B Conconi, D Salerno Uriarte, A Mafrici, S Carugo |
| 448 |
[GO] |
2021―Okt―20 |
Validation of a pandemic-proof, decentralized cardiovascular trial: scalable design produces rapid recruitment, high engagement and protocol adherence in DeTAP (Decentralized Trial in Afib Patients) |
K Josan, A Touros, C Petlura, V Parameswaran, U Grewal, M Senior, T Viethen, H Mundl, C Seninger, J Luithle, K Mahaffey, M Turakhia, R Dash |
| 449 |
[GO] |
2021―Okt―19 |
Atrial fibrillation as a risk factor of severe course of COVID-19 |
A Mielczarek, J D Kasprzak, M Plewka |
| 450 |
[GO] |
2021―Okt―19 |
The correlation of anti-heart antibodies levels with clinical manifestations and outcomes in patients with COVID-19 |
O Blagova, N V Varionchik, V A Zaidenov, P O Savina, N D Sarkisova |
| 451 |
[GO] |
2021―Okt―19 |
Erythrocytes induce vascular dysfunction in COVID-19 |
A Mahdi, A Collado, J Tengbom, T Jiao, T Wodaje, J Yang, J O Lundberg, Z Zhou, J Pernow |
| 452 |
[GO] |
2021―Okt―19 |
Clinical effects of the enhanced external counterpulsation therapy in patients with ischemic chronic heart failure exacerbation COVID-19 |
I Shashenkov, S.A Gabrusenko, S.L Babak, A.G Maliavin |
| 453 |
[GO] |
2021―Okt―19 |
Prognostic value of atrial fibrillation in COVID-19 admitted patients |
A Santos Sanchez, P E Gonzalez-Recio, E Sanchez-Corral, J J Jimenez-Nacher |
| 454 |
[GO] |
2021―Okt―19 |
Frontal QRS/T angle can predict mortality in COVID-19 patients |
R Gunduz, B S Yildiz |
| 455 |
[GO] |
2021―Okt―19 |
Changes in health perception of COVID-19 among patients with aortic diseases: a longitudinal study between the first and second wave of the COVID-19 pandemic |
A Parys, S Klinge, A Doenmez, C Rammos, T Rassaf, A Janosi, J Lortz |
| 456 |
[GO] |
2021―Okt―19 |
Prospective analysis of inflammatory response markers, endothelial dysfunction and hemostasis parameters in COVID-19 associated pneumonia patients with and without type 2 diabetes mellitus |
T Petelina, N Musikhina, K Avdeeva, S Leonovich, L Gapon, E Gorbatenko, Y Sharoyan, E Zueva, E Yaroslavskaya, E Gultyaeva, E Kalyuzhnaya, A Shcherbinina |
| 457 |
[GO] |
2021―Okt―19 |
Acute myocardial infarction in the Covid-19 era: incidence, clinical characteristics and in-hospital outcomes - a multicenter registry |
A Fardman, D Zahger, K Orvin, N Kofman, J Mohsen, O Tsafrir, E Asher, R Rubinshtein, J Jamal, R Efraim, M Halabi, Y Shacham, L H Fortis, R Beigel, S Matetzky |
| 458 |
[GO] |
2021―Okt―19 |
Cardiac implantable electronic devices: a marker for poor outcome in patients with COVID-19 infection |
B Wizman, M Haim, N Yasoor, I Peles, V Novack, Y Konstantino |
| 459 |
[GO] |
2021―Okt―19 |
Arrhythmia patterns in patients with COVID-19 infection during and post hospitalization detected via a patch-based mobile cardiac telemetry system |
O Reynbakh, E D Braunstein, M Hsu, J Ellis, L Crosson, J Lenane, A Krumerman, L Di Biase, K J Ferrick |
| 460 |
[GO] |
2021―Okt―19 |
Higher incidence of stroke in severe COVID-19 is not associated with a higher burden of arrhythmias: comparison to other types of severe pneumonia |
P Jirak, Z Shomanova, R Larbig, D Dankl, N Frank, C Seelmaier, D Butkiene, M Lichtenauer, B Strohmer, J Sackarnd, U Hoppe, J Sindermann, H Reinecke, R Pistulli, L Motloch |
| 461 |
[GO] |
2021―Okt―19 |
The bimodal rise and fall acute coronary syndromes curves paralleling COVID-19 outbreaks |
D Trabattoni, G Teruzzi, P M Ravagnani, G Santagostino Baldi, P Montorsi, G Calligaris, S Galli, A L Bartorelli |
| 462 |
[GO] |
2021―Okt―19 |
Stent-Save a Life international survey on the practice of primary coronary angioplasty during the COVID-19 pandemic |
H Pereira, S S L On Behalf Of Stent Save A Life Initative |
| 463 |
[GO] |
2021―Okt―19 |
STEMI patients in the first and second wave of COVID-19 pandemic in Slovenia |
A Sinkovic, M Krasevec, J Golub, D Suran, M Marinsek, A Markota |
| 464 |
[GO] |
2021―Okt―19 |
Feasibility of remote support for electrophysiological ablation procedures during CoVid-19 pandemics |
A Muessigbrodt, F Demoniere, S Finoly, M Mommarche, J Inamo |
| 465 |
[GO] |
2021―Okt―19 |
Dynamics of myocardial global longitudinal strain in patients with COVID-19 without significant baseline cardiovascular pathology |
S Iakovlev, O Dukhin, E Ryzhkova, E Andreeva, A Kalinskaya |
| 466 |
[GO] |
2021―Okt―19 |
Clinical and morphological characteristics of COVID-19-associated myocarditis |
E A Kogan, A D Kukleva, O V Blagova, Y U S Berezovskij |
| 467 |
[GO] |
2021―Okt―19 |
Cardiac arrest in patients hospitalized for COVID-19: a tertiary medical center retrospective cohort study |
S Luo, J M Du-Fay-De-Lavallaz, J M D Gomez, S Fugar, L Golemi, C J Chiang, T Suboc, J A Simmons, K A Williams, A S Volgman, J Wasserlauf |
| 468 |
[GO] |
2021―Okt―19 |
Expressing a truncated SARS-COV-2 spike protein in mouse heart induces cardiac hypertrophy |
S Negron, C Kessinger, Z Lin |
| 469 |
[GO] |
2021―Okt―19 |
Novel SARS-CoV-2 variants induce higher toxicity in cardiovascular cells |
J U G Wagner, D Bojkova, M Shumliakivska, G S Aslan, J D Kandler, A Hansen, J Krishnan, A M Zeiher, S Ciesek, J Cinatl, S Dimmeler |
| 470 |
[GO] |
2021―Okt―18 |
Cardiac function is normal in most patients recovered from COVID-19 |
J Tangen, P Aukrust, A Barrat-Due, M Troseid, I Christoffer Olsen, K Nezvalova-Henriksen, T Kaasine, A M Dyrhol-Riise, A Rygh Holten, A K Finbraten, T A Josefsen, K C Lee, K H Haugaa, H Skulstad, T Edvardsen |
| 471 |
[GO] |
2021―Okt―18 |
Mid-term endothelial dysfunction post COVID-19 |
S Lampsas, E Oikonomou, G Siasos, N Souvaliotis, A Goliopoulou, C V Mistakidi, P Theofilis, G Vogiatzi, K Kalogeras, E Katsianos, D Tousoulis, M Vavuranakis |
| 472 |
[GO] |
2021―Okt―18 |
The role of cardiovascular calcifications in COVID-19 |
M Toselli, A C Cereda, F G Giannini, A S Scoccia, G G Gallone, A P Palmisano, D V Vignale, A E Esposito |
| 473 |
[GO] |
2021―Okt―18 |
Clinical and echocardiographic risk score predicts need for hospitalization among patients with COVID-19 |
J Kothari, K Shah, T Daly, P Saraiya, I Taha, M Le, H Goel, J Shirani |
| 474 |
[GO] |
2021―Okt―18 |
Long-term post-discharge coagulation abnormalities in patients with moderate to severe COVID-19 |
G Artemyeva, A Kalinskaya, O Dukhin, A Lebedeva, A Rozin, A Shpektor, E Vasilieva |
| 475 |
[GO] |
2021―Okt―18 |
The role of premorbid transthoracic echocardiogram in identifying adverse clinical outcomes in patients admitted with COVID-19 |
C Lee, N Patel, L Panepinto, M Byers, M Ambrosino, S Adusumalli, S Denduluri, J Cohen, M Scherrer-Crosbie |
| 476 |
[GO] |
2021―Okt―18 |
Cardiac involvement in patients recovered from coronavirus disease-2019 (COVID-19): a systematic review |
N Shafiabadi, H Rastad, M Mozafarybazargany, H Talakoob, H Karim |
| 477 |
[GO] |
2021―Okt―18 |
Longitudinal trajectory of cardiac magnetic resonance and cardiopulmonary exercise testing findings in moderate to severe COVID-19 and association with symptoms |
M P Cassar, A J Lewandowski, M Mahmod, C Xie, E M Tunnicliffe, N Petousi, N P Talbot, D Holdsworth, S Neubauer, B Raman |
| 478 |
[GO] |
2021―Okt―18 |
Improvement of outcome prediction of hospitalized patients with COVID-19 by a dual marker strategy using high-sensitive cardiac troponin I and copeptin |
C K Kaufmann, A A Ahmed, M K Kassem, M F Freynhofer, B J Jaeger, G A Aicher, S E Equiluz-Bruck, A S Spiel, F V Vafai-Tabrizi, M G Gschwantler, P F Fasching, J W Wojta, E G Giannitsis, K H Huber |
| 479 |
[GO] |
2021―Okt―18 |
Impact of COVID-19 disease on platelet reactivity and association with inflammatory parameters |
M Ascencio, M Munoz-Esquerre, Y Pascual, M Iglesias, J Sabater, O Murillo, S G Sosa, J A Gomez-Hospital, S Santos, J Comin-Colet, J L Ferreiro |
| 480 |
[GO] |
2021―Okt―18 |
Echocardiographic markers of mortality at 60 days in patients with COVID-19 in the intensive care unit |
J Sprockel, J M Rincon, M Rondon, M Bejarano, N Castellanos, Z Santofimio, H M Cardenas, D Hernandez, J E Parra, J J Diaztagle |
| 481 |
[GO] |
2021―Okt―18 |
Is endothelial dysfunction a driving force of COVID-19 induced coagulopathy? |
O Dukhin, A Kalinskaya, I Molodtsov, A Maltseva, D Sokorev, A Elizarova, K Glebova, D Stonogina, S Shakhidzhanov, I Spiridonov, F Ataullakhanov, L Margolis, A Shpektor, E Vasilieva |
| 482 |
[GO] |
2021―Okt―18 |
Consequences on the right ventricular to pulmonary circulation coupling of COVID-19 infection |
A M Vella, F Bursi, G Santangelo, A Barbieri, F Toriello, F Valli, D Sansalone, S Carugo, M Guazzi |
| 483 |
[GO] |
2021―Okt―18 |
Clinical impact on treatment and prognosis of advanced cardiac imaging with echocardiography in the acute setting of a COVID-19 infection |
M Gonzalez Del Hoyo, L Servato, R Fernandez-Galera, E Rodenas, M Garcia, G Casas, P Jordan, L Herrador, M Bach, F Valente, L Gutierrez, J Baneras, A Evangelista, I Ferreira, J Rodriguez-Palomares |
| 484 |
[GO] |
2021―Okt―18 |
Stress myocardial blood flow reduced after severe COVID-19, not related to symptoms |
P Doeblin, C Goetze, S Al-Tabatabaee, A Berger, F Steinbeis, M Witzenrath, A Faragli, C Stehning, A Chiribiri, C M Scannell, E Alskaf, B Pieske, S Kelle |
| 485 |
[GO] |
2021―Okt―18 |
Prognostic value of coronary artery calcium score in hospitalized COVID-19 patients |
A Motoc, M L Luchian, S Lochy, D Belsack, J Magne, B Roosens, J De Mey, S Boeckstaens, K Van Den Bussche, B Von Kemp, X Galloo, C Francois, C Weytjens, S Droogmans, B Cosyns |
| 486 |
[GO] |
2021―Okt―18 |
Pocket-size ultrasound devices may improve the prompt assessment of Covid-19 patients |
D Filipiak, J D Kasprzak, P Lipiec |
| 487 |
[GO] |
2021―Okt―18 |
Preponderance of right ventricular dysfunction in COVID-19 patients with inflammatory heart disease |
S T Thodeti, D S L Lattanzio, T M K Kuraan, M U K Khalid, D D Drenic, R S R Raghupathy, S V V Vallabhaneni, J R M Mikolich |
| 488 |
[GO] |
2021―Okt―18 |
Initial COVID-19 symptoms are not predictive of post-COVID recovery inflammatory heart disease detected by cardiac MRI |
S T Thodeti, D S L Lattanzio, D D Drenic, T M K Kuraan, M U K Khalid, S V V Vallabhaneni, J R M Mikolich |
| 489 |
[GO] |
2021―Okt―18 |
Association between cardiac pathology and outcomes of patients with COVID-19 using a hand-held ultrasound |
Z Dadon, N Levi, A Orlev, D Belman, E A Alpert, Y Steinmetz, A Wolak, M Glikson, S Gottlieb, A Butnaru |
| 490 |
[GO] |
2021―Okt―18 |
Early microvascular modifications in patients previously hospitalized for COVID-19: comparison with healthy individuals |
P Malerba, C Agabiti Rosei, M Nardin, A Gaggero, G Chiarini, C Rossini, F Fama', V Brami, M A Coschignano, M L Muiesan, D Rizzoni, C De Ciuceis |
| 491 |
[GO] |
2021―Okt―18 |
Cytokine storm induced coagulopathy in septic shock and critical Covid-19: head-to-head comparison |
M D M Dechamps, J De Poortere, P F Laterre, M Octave, A Ginion, V Robaux, J Bodart, D Gruson, M Van Dievoet, J Douxfils, M Derive, A Campion, M Martin, S Horman, C Beauloye |
| 492 |
[GO] |
2021―Okt―18 |
Can echocardiographic parameters predict mortality in COVID-19? |
A Babu, N Eden, Z Meng, D Lamb, R Bhatia, V Voon |
| 493 |
[GO] |
2021―Okt―18 |
Echocardiographic parameters as predictors of three-months mortality in patients with 2019 Coronavirus infection |
T Miranda Aquino, J M Pereira-Forcado, B Ordonez-Salazar, G Dominguez-Trejo, A Rangel-Guerra, J Martinez-Castillo, R J Vazquez-Orozco, A P Guevara-Canseco, S E Perez-Topete, R Aceves-Millan, L Amezcua-Gomez, C Ixcamparij-Rosales |
| 494 |
[GO] |
2021―Okt―18 |
Clinical characteristics and in-hospital outcomes of patients coinfected with Chagas disease and SARS-CoV-2 |
M Marcolino, I Molina, M C Pires, L E F Ramos, R T Silva, M H Guimaraes Junior, R L R Carvalho, A L R M Barros, A L Ribeiro, H Duani, F Anschau, F A Botoni, N R Oliveira, C A Polanczyk, M C P Nunes |
| 495 |
[GO] |
2021―Okt―18 |
The SARS-CoV-2 Spike protein alters human cardiac pericyte function and interaction with endothelial cells through a non-infective mechanism involving activation of CD147 receptor signalling |
E Avolio, M Carrabba, M Kavanagh Williamson, R Milligan, K Gupta, M Gamez, R Foster, I Berger, M Caputo, A Davidson, D Hill, P Madeddu |
| 496 |
[GO] |
2021―Sep―23 |
Transforming community cardiology practice to virtual visits: innovation at Cleveland Clinic during the COVID-19 pandemic |
Gautam V Shah, Ankur Kalra, Umesh N Khot |
| 497 |
[GO] |
2021―Aug―11 |
The 2020 Olympic/Paralympic Games and Covid-19 in Japan |
Hiroaki Shimokawa |
| 498 |
[GO] |
2021―Aug―06 |
Can the US COVID-19 Response Advance Equity in Cardiovascular Health? |
Erica S Spatz, Adam L Beckman, Oyere K Onuma, Elias Mossialos |
| 499 |
[GO] |
2021―Jun―28 |
Maintaining high standards of clinical research during the Covid-19 pandemic: insights from an excellence clinical research centre |
Mattia Lunardi, Darren Mylotte, William Wijns, Yoshinobu Onuma, Osama Soliman, Patrick W Serruys, Faisal Sharif |
| 500 |
[GO] |
2021―Mai―29 |
COVID-19 and the heart: insights from the National Societies of Cardiology Journals |
Jean-Jacques Monsuez |
| 501 |
[GO] |
2021―Mai―13 |
Cardio Egypt 2021: one of the first physical meetings in the era of Covid-19 |
Magdy Abdelhamid, Mohamed Osama, Khaled Shokry |
| 502 |
[GO] |
2021―Mai―08 |
The ongoing impact of COVID-19 on cardiovascular care |
Mark Nicholls |
| 503 |
[GO] |
2021―Apr―16 |
Old and new enemies: psychological stress, occupational stress, COVID-19, and a glimpse of the future |
Filippo Crea |
| 504 |
[GO] |
2021―Apr―07 |
Erratum to: Conducting Clinical Trials in Heart Failure During (and After) the COVID-19 Pandemic: An Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) |
|
| 505 |
[GO] |
2021―Apr―06 |
Hyperinflammation as underlying mechanism predisposing patients with cardiovascular diseases for severe COVID-19 |
Ulf Landmesser, Irina Lehmann, Roland Eils |
| 506 |
[GO] |
2021―Mrz―26 |
COVID-19 and Emissions: An Opportunity for Sustainable Global Health |
Sanjay Rajagopalan, Robert B Jackson, Jagat Narula |
| 507 |
[GO] |
2021―Mrz―26 |
C-reactive protein predicts outcome in COVID-19: is it also a therapeutic target? |
Mark B Pepys |
| 508 |
[GO] |
2021―Feb―05 |
Focus on atrial fibrillation, syncope, and arrhythmias during COVID-19 pandemic |
Filippo Crea |
| 509 |
[GO] |
2021―Feb―04 |
Cardiac arrest occurrence during successive waves of the COVID-19 pandemic: direct and indirect consequences |
Eloi Marijon, Nicole Karam, Xavier Jouven |
| 510 |
[GO] |
2020―Dez―10 |
Innovation in transforming a large-scale scientific medical conference in China entirely online in response to COVID-19 |
Jianping Li, Yuxi Li, Yong Huo |
| 511 |
[GO] |
2020―Nov―29 |
Rheumatic heart disease and COVID-19 |
Andrea Beaton, Liesl Zühlke, Jeremiah Mwangi, Kathryn A Taubert |
| 512 |
[GO] |
2020―Nov―28 |
Response to COVID-19 in a large academic Centre in South Africa |
Ntobeko A B Ntusi |
| 513 |
[GO] |
2020―Okt―30 |
COVID-19 pandemic: a sentiment analysis |
Ashish Kumar, Safi U Khan, Ankur Kalra |
| 514 |
[GO] |
2020―Okt―16 |
The effects of COVID-19 on general cardiology in Italy |
Carmen Anna Maria Spaccarotella, Salvatore De Rosa, Ciro Indolfi |
| 515 |
[GO] |
2020―Okt―12 |
The stethoscope: a potential vector for COVID-19? |
Rajiv S Vasudevan, Khalid Bin Thani, Dhuha Aljawder, Samantha Maisel, Alan S Maisel |
| 516 |
[GO] |
2020―Sep―18 |
Virtual medical education during the COVID-19 pandemic: how to make it work |
Amr Idris, Basel Edris |
| 517 |
[GO] |
2020―Sep―07 |
Collateral implications of the COVID-19 pandemic: belated presentation of infective endocarditis in a young patient |
Eva Toth, Luke Dancy, George Amin-Youssef, Alexandros Papachristidis, Rafal Dworakowski |
| 518 |
[GO] |
2020―Sep―03 |
Understanding COVID-19: in the end it is the endothelium-what else? |
Thomas F Lüscher |
| 519 |
[GO] |
2020―Jul―22 |
COVID-19 and cardiovascular disease |
Mark Nicholls |
| 520 |
[GO] |
2020―Jul―08 |
Acute coronary syndromes in developing countries during the COVID-19 pandemic |
Karim Said, Yasser El-Baghdady, Mohamed Abdel-Ghany |
| 521 |
[GO] |
2020―Jul―05 |
COVID-19 testing |
Roberto Ferrari, Marco De Angelis |
| 522 |
[GO] |
2020―Jun―20 |
Large intracardiac thrombus in a COVID-19 patient treated with prolonged extracorporeal membrane oxygenation implantation |
Dan Hu, Kan Liu, Bixi Li, Zhenhong Hu |
| 523 |
[GO] |
2020―Jun―17 |
EHRA 2020 during COVID-19 days |
Haran Burri, Katja Zeppenfeld, Hein Heidbuchel |
| 524 |
[GO] |
2020―Jun―17 |
Regulating drugs, medical devices, and diagnostic tests in the European Union: early lessons from the COVID-19 pandemic? |
Alan G Fraser, Piotr Szymański, Elizabeth Macintyre, Martin Landray |
| 525 |
[GO] |
2020―Jun―15 |
COVID-19 pandemic in India |
Venkata S Ram, Giridhara R Babu, Dorairaj Prabhakaran |
| 526 |
[GO] |
2020―Jun―14 |
COVID-19 and Katrina: recalcitrant racial disparities |
Harriette G C Van Spall, Clyde W Yancy, Keith C Ferdinand |
| 527 |
[GO] |
2020―Jun―08 |
The saga continues: is COVID-19 a cardiopulmonary disease? |
Thomas F Lüscher |
| 528 |
[GO] |
2020―Jun―06 |
COVID-19 and the healthcare workers |
Ankur Kalra, Erin D Michos, Kavitha M Chinnaiyan |
| 529 |
[GO] |
2020―Jun―03 |
Renin-angiotensin system inhibitors in the COVID-19 pandemic: consequences of antihypertensive drugs |
Luis M Ruilope, Juan Tamargo, Gema Ruiz-Hurtado |
| 530 |
[GO] |
2020―Mai―28 |
Czech Republic and low COVID-19 mortality in the heart of Europe: possible explanations |
Petr Widimsky, Jiri Benes, Alexander M Celko |
| 531 |
[GO] |
2020―Mai―25 |
Acute coronary syndromes during COVID-19 |
Serafina Valente, Francesca Anselmi, Matteo Cameli |
| 532 |
[GO] |
2020―Mai―25 |
Myocardial injury in severe COVID-19 infection |
Allan S Jaffe, John G F Cleland, Hugo A Katus |
| 533 |
[GO] |
2020―Mai―20 |
The ‘Black Death’ and the physician at the time of COVID-19 |
Claudio Rapezzi, Luigi Tavazzi, Roberto Ferrari |
| 534 |
[GO] |
2020―Mai―16 |
COVID-19: (mis)managing an announced Black Swan |
Thomas F Lüscher |
| 535 |
[GO] |
2020―Mai―14 |
Changes in the work mode of cardiologists during the COVID-19 epidemic in Wuhan |
Xiang Cheng, Changsheng Ma, Yaling Han |
| 536 |
[GO] |
2020―Mai―08 |
COVID-19 and congenital heart disease in perspective |
Michael A Gatzoulis |
| 537 |
[GO] |
2020―Mai―08 |
SARS-CoV-2, a novel virus with an unusual cardiac feature: inverted takotsubo syndrome |
Jorge Solano-López, Angel Sánchez-Recalde, José Luis Zamorano |
| 538 |
[GO] |
2020―Mai―07 |
TeleCheck-AF for COVID-19 |
Dominik Linz, Nikki A H A Pluymaekers, Jeroen M Hendriks |
| 539 |
[GO] |
2020―Mai―07 |
What COVID-19 is taking away from us |
Massimo Mapelli |
| 540 |
[GO] |
2020―Mai―07 |
Trying times for heart failure trials during the COVID-19 pandemic |
Judy Ozkan |
| 541 |
[GO] |
2020―Mai―07 |
The Certificate of Advanced Studies (CAS) course adapted to a pandemic |
Francesco Maisano, Agnes Bäker, Maurizio Taramasso, Barbara Jenny, Luca Vicentini, Victoria Jenkins, Martin Andreas, Alberto Pozzoli, Michel Zuber, Carlos A Mestres |
| 542 |
[GO] |
2020―Mai―06 |
Plasma angiotensin-converting enzyme 2: novel biomarker in heart failure with implications for COVID-19 |
Gavin Y Oudit, Marc A Pfeffer |
| 543 |
[GO] |
2020―Mai―06 |
Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy |
Riccardo M Inciardi, Marianna Adamo, Laura Lupi, Dario S Cani, Mattia Di Pasquale, Daniela Tomasoni, Leonardo Italia, Gregorio Zaccone, Chiara Tedino, Davide Fabbricatore, Antonio Curnis, Pompilio Faggiano, Elio Gorga, Carlo M Lombardi, Giuseppe Milesi, Enrico Vizzardi, Marco Volpini, Savina Nodari, Claudia Specchia, Roberto Maroldi, Michela Bezzi, Marco Metra |
| 544 |
[GO] |
2020―Mai―06 |
EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the COVID-19 pandemic |
Alaide Chieffo, Giulio G Stefanini, Susanna Price, Emanuele Barbato, Giuseppe Tarantini, Nicole Karam, Raul Moreno, Gill Louise Buchanan, Martine Gilard, Sigrun Halvorsen, Kurt Huber, Stefan James, Franz-Josef Neumann, Helge Möllmann, Marco Roffi, Guido Tavazzi, Josepa Mauri Ferré, Stephan Windecker, Dariusz Dudek, Andreas Baumbach |
| 545 |
[GO] |
2020―Mai―06 |
Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019 |
Shaobo Shi, Mu Qin, Yuli Cai, Tao Liu, Bo Shen, Fan Yang, Sheng Cao, Xu Liu, Yaozu Xiang, Qinyan Zhao, He Huang, Bo Yang, Congxin Huang |
| 546 |
[GO] |
2020―Apr―30 |
The battle against COVID-19: mortality in Italy |
Roberto Ferrari, Aldo P Maggioni, Luigi Tavazzi, Claudio Rapezzi |
| 547 |
[GO] |
2020―Apr―28 |
Does SARS-CoV-2 cause viral myocarditis in COVID-19 patients? |
Ruihai Zhou |
| 548 |
[GO] |
2020―Apr―27 |
A treatment strategy for acute myocardial infarction and personal protection for medical staff during the COVID-19 epidemic: the Chinese experience |
Yaling Han |
| 549 |
[GO] |
2020―Apr―22 |
Health system, public health, and economic implications of managing COVID-19 from a cardiovascular perspective |
Paul Carter, Michael Anderson, Elias Mossialos |
| 550 |
[GO] |
2020―Apr―18 |
Fulminant myocarditis in the time of coronavirus |
Vittoria Cuomo, Roberta Esposito, Ciro Santoro |
| 551 |
[GO] |
2020―Apr―15 |
Key words to be adopted for COVID-19 research |
Aldo Maggioni, Claudio Rapezzi, Luigi Tavazzi, Roberto Ferrari |
| 552 |
[GO] |
2020―Apr―13 |
Call to action for the cardiovascular side of COVID-19 |
Costanza Emanueli, Lina Badimon, Fabio Martelli, Ines Potočnjak, Irina Carpusca, Emma L Robinson, Yvan Devaux |
| 553 |
[GO] |
2020―Apr―13 |
Donning and doffing of personal protective equipment (PPE) for angiography during the COVID-19 crisis |
Thadathilankal-Jess John, Karim Hassan, Hellmuth Weich |
| 554 |
[GO] |
2020―Apr―13 |
Cell type-specific expression of the putative SARS-CoV-2 receptor ACE2 in human hearts |
Luka Nicin, Wesley Tyler Abplanalp, Hannah Mellentin, Badder Kattih, Lukas Tombor, David John, Jan D Schmitto, Jörg Heineke, Fabian Emrich, Mani Arsalan, Tomas Holubec, Thomas Walther, Andreas M Zeiher, Stefanie Dimmeler |
| 555 |
[GO] |
2020―Apr―08 |
CAPACITY-COVID: a European registry to determine the role of cardiovascular disease in the COVID-19 pandemic |
Marijke Linschoten and, Folkert W Asselbergs |
| 556 |
[GO] |
2020―Apr―08 |
Priorities for Cath labs in the COVID-19 tsunami |
Gianluca Campo, Claudio Rapezzi, Luigi Tavazzi, Roberto Ferrari |
| 557 |
[GO] |
2020―Apr―08 |
Decline of acute coronary syndrome admissions in Austria since the outbreak of COVID-19: the pandemic response causes cardiac collateral damage |
Bernhard Metzler, Peter Siostrzonek, Ronald K Binder, Axel Bauer, Sebastian Johannes Reinstadler |
| 558 |
[GO] |
2020―Apr―07 |
Transient complete heart block in a patient with critical COVID-19 |
Mona Azarkish, Vahideh Laleh far, Masoud Eslami, Reza Mollazadeh |
| 559 |
[GO] |
2020―Apr―07 |
Strategies to control COVID-19 and future pandemics in Africa and around the globe |
Anouar Fanidi, Xavier Jouven, Bamba Gaye |
| 560 |
[GO] |
2020―Apr―07 |
COVID-19 experience in Bergamo, Italy |
Michele Senni |
| 561 |
[GO] |
2020―Apr―07 |
Denominator matters in estimating COVID-19 mortality rates |
Bamba Gaye, Anouar Fanidi, Xavier Jouven |
| 562 |
[GO] |
2020―Apr―07 |
Typical takotsubo syndrome triggered by SARS-CoV-2 infection |
Philippe Meyer, Sophie Degrauwe, Christian Van Delden, Jelena-Rima Ghadri, Christian Templin |
| 563 |
[GO] |
2020―Apr―03 |
COVID-19-related myocarditis in a 21-year-old female patient |
In-Cheol Kim, Jin Young Kim, Hyun Ah Kim, Seongwook Han |
| 564 |
[GO] |
2020―Apr―01 |
The Cardiologist at the time of Coronavirus: a perfect storm |
Claudio Rapezzi, Roberto Ferrari |
| 565 |
[GO] |
2020―Mrz―31 |
Initial COVID-19 affecting cardiac patients in China |
Yaling Han |
| 566 |
[GO] |
2020―Mrz―30 |
Experiences and lesson strategies for cardiology from the COVID-19 outbreak in Wuhan, China, by ‘on the scene’ cardiologists |
Lin Zhang, Yongzhen Fan, Zhibing Lu |
| 567 |
[GO] |
2020―Mrz―25 |
Acute pulmonary embolism and COVID-19 pneumonia: a random association? |
Gian Battista Danzi, Marco Loffi, Gianluca Galeazzi, Elisa Gherbesi |
| 568 |
[GO] |
2020―Mrz―24 |
Life-threatening cardiac tamponade complicating myo-pericarditis in COVID-19 |
Alina Hua, Kevin O’Gallagher, Daniel Sado, Jonathan Byrne |
| 569 |
[GO] |
2020―Mrz―19 |
SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19? |
Gabriela M Kuster, Otmar Pfister, Thilo Burkard, Qian Zhou, Raphael Twerenbold, Philip Haaf, Andreas F Widmer, Stefan Osswald |
| 570 |
[GO] |
2020―Mrz―13 |
Coronaviruses and the cardiovascular system: acute and long-term implications |
Tian-Yuan Xiong, Simon Redwood, Bernard Prendergast, Mao Chen |
| 571 |
[GO] |
2020―Mrz―06 |
Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin |
Hongde Hu, Fenglian Ma, Xin Wei, Yuan Fang |
|
